<?xml version="1.0" encoding="UTF-8"?>
<svg height="777.49" width="545.193" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M49.610 53.720 L532.910 53.720 "/>
  <g begin="text">
   <text y="49.34" x="49.606,54.606,59.606,64.606" svgx:width="0.5,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">486 </text>
   <text y="49.34" x="438.646,443.126,447.606,451.146,453.956,458.336,461.466,464.246,468.826,473.206,476.746,480.286,482.166,486.646,491.336,494.116,499.326,501.306,504.086,509.296,514.506,517.286,520.206,524.786,529.996" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1)</text>
  </g>
  <g begin="text">
   <text y="767.49" x="49.606,57.736,62.426,64.306,67.116,68.996,73.896,75.776,80.156,82.936,87.516,91.366,93.246,97.626,100.756,105.236,108.776,110.656,114.196,116.976,119.376,123.856,128.546,131.676,136.366,141.056" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="767.49" x="142.936,145.716,150.716,155.716,160.716,165.716,167.906,170.686,175.686,180.686,182.876,185.656,188.886,193.466,198.466,201.696,204.476,209.476,214.476,219.476,224.476,229.476,234.476" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="767.42" x="466.181,473.891,477.741,479.931,482.121,485.971,490.241,494.511,499.301,504.301,509.301,514.201,516.391,520.771,526.291" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M49.610 468.300 L85.570 468.300 "/>
  <g begin="text">
   <text y="77.103" x="49.606,54.106,58.102,62.098,64.6,67.102,71.602,76.102,78.667,82.663,87.163,91.663,94.165,96.667,100.168,102.733,106.729,111.229,114.226,118.726,121.228,123.73,127.726,132.226,134.791,137.293,141.793,144.295,148.795,151.36,155.86,158.425,161.926,165.922,170.422,174.922,178.918,183.418,185.92,188.422,192.418,194.92,197.485,201.481,205.981,210.481,214.981,217.978,220.48,223.981,226.546,231.046,234.043,236.608,241.108,245.608,248.173,252.169,256.165,258.667,261.169,265.669,269.665,272.23,276.226,280.726,285.226" svgx:width="0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.28,0.39,0.25,0.44,0.5,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.28,0.5,0.25,0.5,0.25,0.39,0.44,0.5,0.5,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.44,0.5,0.5,0.5,0.33,0.28,0.39,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">healthy adults enrolled into 5 sequential cohorts of 12 active and </text>
   <text y="88.101" x="49.606,54.106,56.356,57.157,61.657,64.159,68.155,72.151,76.147,80.647,85.147,87.397,88.198,91.699,96.199,100.699,103.201,107.197,111.193,113.695,117.196,119.446,121.696,122.497,127.996,131.992,135.988,140.488,142.738,143.539,147.535,152.035,156.535,161.035,164.032,166.534,168.784,169.585,172.582,176.578,180.574,184.57,187.072,191.572,195.568,200.068,202.318,203.119,207.619,209.869,210.67,215.17,219.166,223.666,227.167,229.417,230.218,234.214,236.716,238.966,239.767,246.769,250.765,253.267,257.767,260.269,264.265,268.765,272.761,277.261,281.257,285.253" svgx:width="0.5,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.25,0.55,0.61,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.33,0.28,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.25,0.55,0.5,0.44,0.5,0.39,0.25,0.55,0.44,0.28,0.25,0.55,0.78,0.44,0.28,0.5,0.28,0.44,0.5,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">3 placebo subjects. Each cohort received 7 days at maintenance </text>
   <text y="99.099" x="49.606,54.106,58.606,62.107,66.103,68.614,71.611,76.111,78.613,81.115,85.615,92.113,94.615,99.115,103.615,106.126,110.626,115.126,117.637,120.139,124.639,127.15,131.65,134.161,138.661,142.657,147.157,150.658,153.169,157.669,160.666,163.177,167.677,172.177,175.174,177.676,180.178,182.68,185.677,189.673,192.175,194.677,199.177,203.677,206.179,208.69,213.694,218.194,221.191,228.193,232.693,235.195,239.191,241.693,244.195,248.695,253.195,255.706,260.206,262.717,266.713,269.215,271.726,276.226,280.726,285.226" svgx:width="0.5,0.5,0.39,0.44,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.25,0.5,0.44,0.5,0.39,0.25,0.5,0.33,0.25,0.5,0.5,0.33,0.28,0.28,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.28,0.25,0.56,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.25,0.44,0.28,0.25,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">dose following up to 4 days of up-titration: Formulation 1 at 200 </text>
   <text y="110.097" x="49.606,56.608,61.108,63.358,64.204,70.207,73.204,79.702,81.952,82.798,87.298,90.295,92.545,93.391,97.891,102.391,106.891,109.141,109.987,116.989,121.489,123.739,124.585,130.588,133.585,140.083,142.333,143.179,146.176,149.173,153.169,156.67,159.172,163.168,167.668,170.665,173.167,175.417,176.263,181.267,185.767,188.764,195.766,200.266,202.768,206.764,209.266,211.768,216.268,220.768,223.018,223.864,228.364,230.614,231.46,235.456,237.958,240.208,241.054,245.554,250.054,254.554,256.804,257.65,264.652,269.152,271.402,272.248,278.746,285.244" svgx:width="0.78,0.5,0.25,0.55,0.67,0.33,0.72,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.78,0.5,0.25,0.55,0.67,0.33,0.72,0.25,0.55,0.33,0.33,0.44,0.39,0.28,0.44,0.5,0.33,0.28,0.25,0.55,0.56,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.78,0.5,0.25,0.55,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mg BID or 400 mg BID (fasted); Formulation 2 at 800 mg QD </text>
   <text y="121.095" x="49.606,52.603,55.6,59.596,64.096,66.346,68.74,73.24,76.237,78.487,80.881,83.878,87.874,91.375,93.877,97.873,102.373,105.37,107.62,110.014,114.01,118.51,123.01,125.26,127.654,132.154,136.654,141.154,143.404,145.798,152.8,157.3,159.55,161.944,167.947,170.944,177.442,179.692,182.086,185.083,188.08,192.076,196.576,199.573,201.823,204.073,205.972,212.47,216.97,219.22,221.614,225.61,230.11,234.61,237.112,239.614,242.116,246.616,251.116,255.112,257.614,259.864,262.258,266.254,270.754,275.254,279.754,282.751,285.253" svgx:width="0.33,0.33,0.44,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.39,0.28,0.44,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.78,0.5,0.25,0.55,0.67,0.33,0.72,0.25,0.55,0.33,0.33,0.44,0.5,0.33,0.25,0.25,0.55,0.72,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.5,0.33,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(fed or fasted) and 500 mg BID (fed). An additional cohort </text>
   <text y="132.093" x="49.606,52.603,56.599,60.595,64.591,67.093,71.593,75.589,80.089,82.339,83.05,89.548,97.549,102.553,104.803,105.514,108.511,113.38,117.376,121.372,124.369,126.871,131.371,135.367,138.364" svgx:width="0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.72,0.89,0.56,0.25,0.55,0.33,0.61,0.44,0.44,0.33,0.28,0.5,0.44,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">received DMF (Tecfidera</text>
   <text y="129.583" x="142.359" svgx:width="0.76" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">®</text>
   <text y="132.103" x="146.805,149.055,151.305,152.016,158.019,164.517,167.514,172.014,176.514,179.511,181.761,182.472,186.972,191.472,195.972,198.222,198.933,205.935,210.435,212.685,213.396,219.399,222.396,228.894,231.144,231.855,234.852,237.849,241.845,245.346,247.848,251.844,256.344,258.846,261.096,261.807,264.804,268.8,273.3,275.55,276.261,280.761,285.261" svgx:width="0.25,0.25,0.55,0.67,0.72,0.33,0.5,0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.78,0.5,0.25,0.55,0.67,0.33,0.72,0.25,0.55,0.33,0.33,0.44,0.39,0.28,0.44,0.5,0.28,0.25,0.55,0.33,0.44,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, BG-12) 240 mg BID (fasted; fed on </text>
   <text y="143.101" x="49.605,56.103,60.099,64.599,66.507,71.007,74.004,76.254,78.162,83.166,89.664,91.572,96.072,99.069,100.977,108.978,116.979,121.983,123.891,126.393,130.893,132.801,137.301,139.803,144.303,148.803,153.303,155.211,159.207,163.707,168.207,170.115,174.615,177.117,181.113,184.614,191.616,195.612,197.52,204.018,208.014,211.011,215.007,216.915,221.415,225.411,227.913,231.909,234.906,241.908,244.41,248.91,252.906,257.406,259.314,263.814,268.314,270.222,276.72,280.716,285.216" svgx:width="0.72,0.44,0.5,0.25,0.5,0.33,0.25,0.25,0.56,0.72,0.25,0.5,0.33,0.25,0.89,0.89,0.56,0.25,0.28,0.5,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.44,0.39,0.78,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.72,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Day 7). PK of MMF in blood and plasma were determined on Day </text>
   <text y="154.099" x="49.605,54.105,56.517,59.514,66.012,70.008,74.508,78.009,80.421,84.921,87.333,91.329,95.829,100.329,102.741,107.241,109.653,112.65,117.15,120.147,122.559,129.057,137.058,142.062,145.059,147.309,149.721,155.724,158.226,160.728,165.228,167.73,171.726,175.722,178.224,180.636,183.138,187.134,191.634,195.135,197.547,204.045,208.041,211.038,215.034,217.446,221.442,224.943,228.444,232.44,235.941,239.442,243.438,247.938,250.35,254.346,256.848,259.26,262.761,266.757,269.754,273.75,277.746,282.246" svgx:width="0.5,0.25,0.33,0.72,0.44,0.5,0.39,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.25,0.33,0.5,0.33,0.25,0.72,0.89,0.56,0.33,0.25,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.44,0.5,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.44,0.28,0.25,0.39,0.44,0.33,0.44,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">7 (Days 6 and 7 for DMF). Clinical labs were assessed at screen-</text>
   <text y="165.097" x="49.605,52.107,56.607,61.107,63.357,65.607,66.417,70.917,74.913,78.414,82.41,84.912,87.414,91.914,95.91,98.16,100.41,101.22,107.718,111.714,116.214,118.464,119.274,123.774,126.024,126.834,129.831,134.331,136.581,137.391,141.891,145.887,150.387,152.637,153.447,157.443,160.44,162.942,166.938,169.935,172.185,172.995,175.497,179.493,182.994,185.496,187.746,188.556,193.056,197.556,201.057,205.053,208.05,210.3,211.11,215.106,219.606,224.106,226.356,227.166,230.163,234.663,237.165,239.667,244.167,250.665,253.662,258.162,262.662,264.912,265.722,268.719,273.219,276.216,280.716,285.216" svgx:width="0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.55,0.72,0.44,0.5,0.25,0.55,0.5,0.25,0.55,0.33,0.5,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.28,0.44,0.39,0.28,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing, baseline, Day 8 (1 day after last dose) and follow-up (8-10 </text>
   <text y="176.095" x="49.605,54.105,58.101,62.601,66.102,68.352,72.348,75.345,77.847,81.843,84.84,87.09,89.592,93.588,97.089,99.591,101.841,106.341,110.841,114.342,118.338,121.335" svgx:width="0.5,0.44,0.5,0.39,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.28,0.44,0.39,0.28,0.25,0.5,0.5,0.39,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">days after last dose).</text>
   <text y="187.093" x="49.605,56.103,60.099,63.6,68.604,71.106,74.103,77.604,80.601" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="187.093" x="82.788,90.789,94.785,98.781,103.281,105.468,109.464,112.461,116.457,120.453,122.64,127.14,131.64,136.14,140.136,143.133,145.32,147.822,152.322,156.318,158.505,162.501,167.001,169.998,174.498,178.494,180.681,185.181,189.681,193.677,196.674,198.861,203.361,207.861,210.048,214.548,219.048,223.548,226.545,230.046,232.233,235.23,241.728,248.226" svgx:width="0.89,0.44,0.44,0.5,0.25,0.44,0.33,0.44,0.44,0.25,0.5,0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.33,0.5,0.44,0.25,0.5,0.5,0.44,0.33,0.25,0.5,0.5,0.25,0.5,0.5,0.5,0.33,0.39,0.25,0.33,0.72,0.72,0.67" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Mean area under the curve over 24 hours (AUC</text>
   <text y="189.173" x="254.218,256.494,258.77,260.232,263.157" svgx:width="0.39,0.39,0.25,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">ss,24</text>
   <text y="187.103" x="266.082,269.079,271.266,275.766,279.762,282.264" svgx:width="0.33,0.25,0.5,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">) val-</text>
   <text y="198.101" x="49.605,54.105,58.101,61.602,64.419,66.921,71.421,74.238,78.738,81.24,85.236,88.737,95.739,99.735,102.552,110.553,118.554,123.558,126.375,132.873,136.869,139.866,143.862,146.679,151.179,155.679,160.179,164.679,167.496,171.492,175.992,180.492,183.309,187.809,192.309,196.809,201.309,204.126,208.626,213.126,217.626,222.126,225.123,227.625,234.627,239.793,242.61,245.607,250.107,253.104,255.921,260.421,264.921,269.421,272.238,276.234,280.734,285.234" svgx:width="0.5,0.44,0.39,0.25,0.28,0.5,0.25,0.5,0.28,0.44,0.39,0.78,0.44,0.25,0.89,0.89,0.56,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.28,0.78,0.61,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ues in plasma MMF were 3670 and 6910 ng*hr/mL for 200 and </text>
   <text y="209.099" x="49.605,54.105,58.605,63.105,65.688,72.69,77.19,79.773,85.776,88.773,95.271,97.854,102.858,107.358,110.355,117.357,121.857,124.359,128.355,130.857,133.359,137.859,142.359,144.942,149.442,151.692,154.275,157.272,161.268,164.769,169.269,173.265,177.261,179.763,182.265,186.765,190.761,193.263,197.763,200.346,204.342,208.842,213.342,215.925,220.425,224.925,229.425,233.925,236.508,241.008,245.508,250.008,254.508,257.505,260.007,267.009,272.175,274.758,277.755,282.255,285.252" svgx:width="0.5,0.5,0.5,0.25,0.78,0.5,0.25,0.67,0.33,0.72,0.25,0.56,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.25,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.28,0.78,0.61,0.25,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">400 mg BID Formulation 1, respectively and 7010 ng*hr/mL for </text>
   <text y="220.097" x="49.605,56.103,64.104,69.108,71.358,72.168,75.165,78.162,82.158,85.659,88.161,92.157,96.657,99.654,101.904,104.154,104.964,112.965,116.961,120.957,125.457,127.707,128.517,136.518,144.519,149.523,152.088,158.586,165.084" svgx:width="0.72,0.89,0.56,0.25,0.55,0.33,0.33,0.44,0.39,0.28,0.44,0.5,0.33,0.25,0.25,0.55,0.89,0.44,0.44,0.5,0.25,0.55,0.89,0.89,0.56,0.25,0.72,0.72,0.67" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DMF (fasted). Mean MMF AUC</text>
   <text y="222.173" x="171.094,173.37,175.645,177.108,180.033" svgx:width="0.39,0.39,0.25,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">ss,24</text>
   <text y="220.103" x="182.958,185.208,186.018,188.52,193.02,195.27,196.08,200.58,203.082,207.078,210.579,217.581,221.577,223.827,224.637,231.135,235.131,238.632,240.882,241.692,246.192,250.692,255.192,259.692,261.942,264.192,265.002,269.502,274.002,278.502,283.002,285.252" svgx:width="0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.44,0.39,0.78,0.44,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> in plasma was 4490, 5080, </text>
   <text y="231.101" x="49.605,53.601,58.101,62.601,64.455,68.955,73.455,77.955,82.455,84.309,88.809,93.309,97.809,102.309,105.306,107.808,114.81,119.976,121.83,124.827,129.327,132.324,134.178,138.678,143.178,147.678,149.532,156.534,161.034,162.888,169.386,175.884,177.738,180.735,183.732,187.728,191.229,193.731,197.727,202.227,205.224,207.474,209.328,213.828,218.328,222.828,224.682,231.684,236.184,238.038,244.536,251.034,252.888,255.885,258.882,262.878,267.378,270.375,272.229,276.225,280.725,285.225" svgx:width="0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.28,0.78,0.61,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.5,0.25,0.78,0.5,0.25,0.72,0.72,0.25,0.33,0.33,0.44,0.39,0.28,0.44,0.5,0.33,0.25,0.25,0.5,0.5,0.5,0.25,0.78,0.5,0.25,0.72,0.72,0.25,0.33,0.33,0.44,0.5,0.33,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 5510 ng*hr/mL for 800 mg QD (fasted), 800 mg QD (fed) and </text>
   <text y="242.099" x="49.605,54.105,58.605,63.105,65.355,72.357,76.857,79.107,85.11,88.107,94.605,96.855,101.859,106.359,109.356,116.358,120.858,123.36,127.356,129.858,132.36,136.86,141.36,143.61,148.11,150.36,152.61,155.607,159.603,163.104,167.604,171.6,175.596,178.098,180.6,185.1,189.096,191.598,195.513" svgx:width="0.5,0.5,0.5,0.25,0.78,0.5,0.25,0.67,0.33,0.72,0.25,0.56,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.25,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">500 mg BID Formulation 2, respectively.</text>
   <text y="253.097" x="61.602,67.605,72.105,74.607,79.107,81.177,87.675,92.679,97.179,101.679,106.179,110.679,115.179,117.249,121.245,125.745,130.245,132.315,138.813,146.814,151.818,153.888,156.885,160.881,165.381,169.881,173.877,177.873,182.373,184.443,188.943,191.445,195.945,200.445,204.945,207.015,209.517,214.017,221.019,225.519,230.019,234.519,238.515,243.015,245.517,249.513,253.014,255.084,259.08,261.582,263.652,270.15,274.146,278.646,280.716,285.216" svgx:width="0.67,0.5,0.28,0.5,0.25,0.72,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.72,0.89,0.56,0.25,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.44,0.28,0.25,0.72,0.44,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Both XP23829 and DMF reduced blood lymphocytes at Day 8 </text>
   <text y="264.095" x="49.605,53.601,58.101,65.103,69.603,73.599,76.596,80.592,85.092,87.342,88.395,90.897,95.397,97.647,98.7,103.2,107.196,110.697,114.693,117.195,119.697,124.197,128.193,130.443,132.693,133.746,138.246,142.746,145.248,147.498,148.551,151.548,155.544,160.044,164.544,168.54,171.042,173.544,178.044,182.544,186.045,188.295,189.348,195.846,198.348,200.85,205.35,207.6,208.653,215.151,220.155,224.655,229.155,233.655,238.155,242.655,244.905,245.958,252.456,256.452,259.449,263.445,265.695,266.748,273.75,278.25,281.247,285.243" svgx:width="0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.72,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.78,0.5,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">compared to baseline, but reductions with XP23829 were more </text>
   <text y="275.093" x="49.605,54.105,57.102,61.602,66.102,70.602,75.102,79.602,83.598,87.594,92.094,94.344,96.324,102.822,107.322,111.318,115.818,118.068,120.048,124.044,128.544,135.546,140.046,144.042,147.039,151.035,155.535,157.785,159.765,162.267,166.767,169.017,170.997,177.495,185.496,189.78,192.03,194.28,196.098,201.597,206.097,210.093,212.343,214.323,221.325,225.321,229.317,233.817,236.067,238.047,242.043,246.543,250.539,255.039,259.539,263.535,265.785,267.765,270.762,273.759,278.259,285.261" svgx:width="0.5,0.33,0.5,0.5,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.55,0.72,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.89,0.56,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.55,0.33,0.33,0.5,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pronounced when compared to DMF. The mean change from </text>
   <text y="286.091" x="49.605,54.105,58.101,61.602,65.598,68.1,70.602,75.102,79.098,81.519,84.021,88.521,90.942,93.444,97.944,104.946,109.446,113.946,118.446,122.442,126.942,129.444,133.44,136.941,139.362,142.359,146.859,149.28,153.78" svgx:width="0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.33,0.5,0.25,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">baseline in lymphocytes (x 10</text>
   <text y="283.583" x="158.274,161.199" svgx:width="0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">9 </text>
   <text y="286.103" x="162.771,165.273,170.772,173.769,176.19,179.187,183.183,187.683,192.183,196.179,200.679,203.1,206.097,209.094,213.594,220.596,223.017,226.014,230.514,232.764,237.264,241.764,244.185,246.687,251.187,253.608,256.605,261.105,263.355,267.855,272.355,274.776,277.773,282.273,285.271" svgx:width="0.28,0.61,0.33,0.25,0.33,0.44,0.5,0.5,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.33,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.25,0.33,0.5,0.25,0.5,0.5,0.25,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">/L) ranged from -0.07 to -0.44 for </text>
   <text y="297.101" x="49.605,54.609,59.109,62.106,69.108,73.608,76.11,80.106,82.608,85.11,89.61,94.11,96.531,101.031,103.452,107.448,111.948,116.448,118.86,121.857,126.357,128.607,133.107,137.607,140.028,142.53,147.03,149.451,152.448,156.948,159.198,163.698,168.198,170.619,173.616,178.116,181.113,183.534,188.538,193.038,196.035,203.037,207.537,210.039,214.035,216.537,219.039,223.539,228.039,230.451,234.951,237.372,240.369,244.365,248.865,255.867,260.367,264.363,267.361,271.357,275.857,278.277,280.78,285.28" svgx:width="0.56,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.33,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.25,0.33,0.5,0.25,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.56,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.25,0.33,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Formulation 1 and -0.84 to -1.16 for Formulation 2 (compared to </text>
   <text y="308.099" x="49.605,52.603,57.103,59.353,63.853,68.353,70.692,73.689,78.189,81.187,83.526,90.024,98.025,103.029,105.369,109.365,113.865,118.365,120.705,123.702,128.202,130.452,134.952,139.452,141.792,144.789,149.289,152.286,154.626,159.126,161.628,165.624,169.62,173.616,178.116,182.616,185.613,187.863,190.203,195.207,199.707,206.709,211.209,215.709,220.209,224.205,228.705,231.207,235.203,238.704,241.044,245.544,248.046,252.546,254.886,259.386,263.886,266.388,268.728,273.228,276.225,280.725,285.225" svgx:width="0.33,0.5,0.25,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.72,0.89,0.56,0.25,0.44,0.5,0.5,0.25,0.33,0.5,0.25,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">-0.32 for DMF and -0.23 for placebo). Lymphocytes did not drop </text>
   <text y="319.097" x="49.605,54.105,58.101,60.603,65.104,71.602,74.382,78.882,81.132,85.632,88.413,92.913,95.694,100.194" svgx:width="0.5,0.44,0.28,0.5,0.72,0.25,0.5,0.25,0.5,0.25,0.5,0.25,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">below 0.5 x 10</text>
   <text y="316.583" x="104.688,107.613" svgx:width="0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">9 </text>
   <text y="319.103" x="109.419,111.921,117.087,119.868,122.37,126.87,129.651,133.647,138.147,142.647,145.428,148.929,153.429,157.929,160.431,164.427,168.423,170.925,173.175,175.956,180.96,185.46,192.462,196.962,201.462,205.962,209.958,214.458,216.96,220.956,224.457,227.238,230.235,234.231,236.733,241.233,244.23,248.73,252.726,257.226,260.007,262.509,267.009,269.79,274.29,278.286,282.282,285.279" svgx:width="0.28,0.61,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.25,0.61,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.33,0.44,0.28,0.5,0.33,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">/L in any subject. Lymphocytes returned to near </text>
   <text y="330.101" x="49.605,54.105,58.101,61.602,65.598,68.1,70.602,75.102,79.098,81.348,83.85,87.846,92.346,96.342,98.844,102.345,104.595,108.591,111.093,113.343,116.34,120.84,123.342,125.844,130.344,136.842,139.839,144.339,148.839" svgx:width="0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.44,0.28,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">baseline levels at follow-up.</text>
   <text y="341.099" x="49.605,56.103,60.603,65.607,69.603,72.105,77.109,80.61,83.112,87.612,92.616,96.117,99.114" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="341.099" x="101.139,107.637,112.641,117.141,121.641,126.141,130.641,135.141,137.166,141.666,144.663,149.163,153.663,156.165,160.665,164.661,169.161,171.186,174.687,177.189,184.191,186.693,189.195,193.191,196.188,198.213,201.21,206.214,210.714,213.711,220.713,225.213,227.715,231.711,234.213,236.715,241.215,245.715,247.74,252.24,255.237,257.262,261.762,264.759,266.784,273.786,278.286,281.283,285.279" svgx:width="0.72,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.5,0.33,0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.33,0.56,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.33,0.25,0.78,0.5,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">XP23829 provided similar (Formulation 1) or more </text>
   <text y="352.097" x="49.605,53.106,57.606,61.107,63.609,67.605,70.107,74.607,78.603,83.103,85.353,86.19,89.187,94.191,98.691,101.688,108.69,113.19,115.692,119.688,122.19,124.692,129.192,133.692,135.942,136.779,141.279,144.276,146.526,147.363,155.364,163.365,168.369,170.619,171.456,175.452,179.952,184.452,188.952,192.453,196.953,199.95,203.946,206.196,207.024,211.02,215.52,222.522,227.022,231.018,234.015,238.011,242.511,244.761,245.598,248.1,252.6,254.85,255.687,262.185,270.186,275.19,277.44,278.277,280.779,285.279" svgx:width="0.39,0.5,0.39,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.33,0.56,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.89,0.89,0.56,0.25,0.55,0.44,0.5,0.5,0.5,0.39,0.5,0.33,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.89,0.56,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sustained (Formulation 2) MMF exposure compared to DMF in </text>
   <text y="363.095" x="49.605,54.105,58.101,62.097,64.599,67.101,71.601,76.101,78.351,79.215,82.716,87.216,91.716,94.218,98.214,102.21,104.712,108.213,110.463,113.082,119.58,122.577,125.079,129.075,132.072,134.322,135.186,139.686,144.186,147.687,150.189,154.689,159.189,161.439,162.303,165.3,169.8,172.797,175.047,175.911,180.078,184.578,186.828,187.692,192.192,196.188,200.688,204.189,206.439,208.689,209.553,216.051,221.055,225.555,230.055,234.555,239.055,243.555,245.805,246.669,249.666,253.662,257.163,261.663,264.165,266.667,270.663,275.163,277.413,278.277,280.779,285.279" svgx:width="0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.25,0.72,0.33,0.28,0.44,0.33,0.25,0.55,0.5,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.39,0.25,0.25,0.55,0.72,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">healthy subjects. After dosing for 11 days, XP23829 resulted in </text>
   <text y="374.093" x="49.605,54.105,57.102,61.098,65.094,67.596,71.592,74.589,77.046,80.043,84.039,88.539,93.039,97.035,99.537,102.039,106.539,111.039,114.54,116.997,119.994,122.991,127.491,134.493,136.95,141.45,145.446,148.947,152.943,155.445,157.947,162.447,166.443,168.9,171.402,175.902,178.359,182.859,185.361,189.861,194.361,198.861,201.318,203.82,208.32,215.322,219.822,224.322,228.822,232.818,237.318,239.82,243.816,247.317,249.774,253.77,258.27,265.272,269.772,273.768,276.765,280.761,285.261" svgx:width="0.5,0.33,0.44,0.44,0.28,0.44,0.33,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.5,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">greater reductions from baseline in blood lymphocytes compared </text>
   <text y="385.091" x="49.605,52.107,56.607,59.271,65.769,73.77,78.054,80.304,82.806,88.305,92.805,96.801,99.465,103.461,105.963,108.465,112.965,115.467,119.463,123.459,125.961,128.625,132.621,136.617,139.119,141.621,146.121,148.623,151.125,155.625,158.289,162.789,165.786,168.45,174.948,179.952,184.452,188.952,193.452,197.952,202.452,205.116,211.614,214.116,216.618,219.12,221.784,226.284,230.28,232.944,236.94,241.44,245.94,248.442,252.942,255.939,259.935,264.435,267.099,269.601,274.101,276.765,280.761,285.261" svgx:width="0.28,0.5,0.25,0.72,0.89,0.56,0.25,0.25,0.61,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.72,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.72,0.28,0.28,0.28,0.25,0.5,0.44,0.25,0.44,0.5,0.5,0.28,0.5,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to DMF. The clinical activity of XP23829 will be explored in an </text>
   <text y="396.089" x="49.605,54.105,58.605,62.601,67.101,74.103,76.605,81.105,85.605,87.855,89.313,93.813,98.313,102.309,105.81,109.806,112.056,113.514,118.014,120.264,122.514,123.972,128.472,132.972,136.473,140.469,143.466,146.463,150.459,154.959,159.459,161.961,166.461,170.961,173.211,174.669,178.665,181.167,183.669,188.169,190.671,194.667,198.663,201.165,203.415,204.873,208.374,210.876,215.376,219.876,224.376,226.626,228.084,230.586,235.086,237.336,238.794,245.796,250.296,254.796,258.792,261.789,265.785,268.287,272.283,275.28,277.782,282.282" svgx:width="0.5,0.5,0.44,0.5,0.78,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.44,0.39,0.44,0.25,0.55,0.5,0.25,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.33,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.78,0.5,0.5,0.44,0.33,0.44,0.28,0.44,0.33,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">upcoming phase 2, dose-ranging clinical study in moderate-to-</text>
   <text y="407.087" x="49.605,53.106,57.102,61.602,65.598,68.595,72.591,74.841,79.341,81.843,85.839,90.339,94.839,98.835,101.085,105.585,109.086,113.586,116.583,119.085,123.081,126.582,129.084,132.585" svgx:width="0.39,0.44,0.5,0.44,0.33,0.44,0.25,0.5,0.28,0.44,0.5,0.5,0.44,0.25,0.5,0.39,0.5,0.33,0.28,0.44,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">severe plaque psoriasis.</text>
   <text y="434.087" x="49.605,55.104,59.604,64.104" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P959</text>
   <text y="445.085" x="49.605,55.608,59.604,63.6,66.102,69.099,71.601,76.605,81.609,86.109,93.606,96.108,101.112,105.108,107.358,114.855,118.851,122.847,127.851,132.351,137.355,139.857,143.358,150.855,153.105,157.605,160.602,162.852,167.352,171.348,174.345,176.847,181.347,186.351,189.348,191.598,194.1,196.602,201.606,206.61,209.112,214.116,218.616,220.866,225.87,229.866,233.862,237.858,240.36,242.862,247.866,250.368,254.364,258.864,261.366" svgx:width="0.67,0.44,0.44,0.28,0.33,0.28,0.56,0.56,0.5,0.83,0.28,0.56,0.44,0.25,0.83,0.44,0.44,0.56,0.5,0.56,0.28,0.39,0.83,0.25,0.5,0.33,0.25,0.5,0.44,0.33,0.28,0.5,0.56,0.33,0.25,0.28,0.28,0.56,0.56,0.28,0.56,0.5,0.25,0.56,0.44,0.44,0.44,0.28,0.28,0.56,0.28,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Teriflunomide mechanism of action: linking preclinical </text>
   <text y="456.083" x="49.605,53.601,58.101,60.603,65.607,69.603,74.607,78.603,82.599,84.849,87.846,92.346,94.596,98.592,101.094,103.596,108.6,111.102,115.098,119.598,122.1,124.35,128.346,131.343,134.34,136.842,140.838,145.338,149.334,153.834,156.084,160.584,165.588,170.592,172.842,176.343,180.843,183.84,187.836,190.833" svgx:width="0.44,0.5,0.28,0.56,0.44,0.56,0.44,0.44,0.25,0.33,0.5,0.25,0.44,0.28,0.28,0.56,0.28,0.44,0.5,0.28,0.25,0.44,0.33,0.33,0.28,0.44,0.5,0.44,0.5,0.25,0.5,0.56,0.56,0.25,0.39,0.5,0.33,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">evidence to clinical efficacy and safety</text>
   <text y="467.081" x="49.605,56.193,58.533,67.119,69.711,73.797,78.387,82.977" svgx:width="0.72,0.25,0.94,0.28,0.44,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">H Wiendl</text>
   <text y="464.583" x="85.57" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.103" x="88.553,90.893,93.233,99.821,102.161,107.255,111.341,115.427,120.017,124.607,128.693" svgx:width="0.25,0.25,0.72,0.25,0.56,0.44,0.44,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Pachner</text>
   <text y="464.583" x="131.78" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="467.103" x="134.763,137.103,139.443,144.537,146.877,153.465,158.055,162.645,166.731,169.818,174.408" svgx:width="0.25,0.25,0.56,0.25,0.72,0.5,0.5,0.44,0.33,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, F Odoardi</text>
   <text y="464.583" x="177.0" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="467.103" x="179.983,182.323,184.663,190.252,192.592,199.18,203.266,206.353,208.945,213.031,217.621,220.213,224.299" svgx:width="0.25,0.25,0.61,0.25,0.72,0.44,0.33,0.28,0.44,0.5,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Vartanian</text>
   <text y="464.583" x="228.889" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="467.103" x="231.872,234.212,236.552,241.646,247.235,249.575,256.163,260.159" svgx:width="0.25,0.25,0.56,0.61,0.25,0.72,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, PL De </text>
   <text y="478.101" x="49.604,53.195,57.281,61.871,65.957" svgx:width="0.39,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Jager</text>
   <text y="475.583" x="69.046" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">5</text>
   <text y="478.103" x="72.029,74.369,76.709,80.3,82.64,89.228,93.314,97.904,100.496,104.582" svgx:width="0.25,0.25,0.39,0.25,0.72,0.44,0.5,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Kaplan</text>
   <text y="475.583" x="109.172" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">6</text>
   <text y="478.103" x="112.155,114.495,116.835,121.929,124.269,132.36,136.446,141.036,145.626,150.216,154.806,157.893,164.481,168.567,172.653,177.243,181.329,184.416,189.006" svgx:width="0.25,0.25,0.56,0.25,0.89,0.44,0.5,0.5,0.5,0.5,0.33,0.72,0.44,0.44,0.5,0.44,0.33,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, F Menguy-Vacheron</text>
   <text y="475.583" x="193.596" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">7</text>
   <text y="478.103" x="196.579,198.919,201.259,206.353,208.693,214.282,217.369,221.959,225.046,228.133,230.725,235.315,239.401" svgx:width="0.25,0.25,0.56,0.25,0.61,0.33,0.5,0.33,0.33,0.28,0.5,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Truffinet</text>
   <text y="475.583" x="241.993" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">8</text>
   <text y="478.103" x="244.976,247.226,249.656" svgx:width="0.25,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="489.101" x="49.604,56.192,58.532,64.625,68.711,71.798,74.885,81.473" svgx:width="0.72,0.25,0.67,0.44,0.33,0.33,0.72,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A Bar-Or</text>
   <text y="486.583" x="84.562" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">9</text>
   <text y="497.581" x="49.608" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="500.103" x="52.531,59.029,63.529,66.031,70.027,74.023,77.524,81.025,83.527,86.029,90.025,92.275,96.775,99.277,101.527,109.024,113.524,118.024,121.525,124.027,128.023,131.524,133.774,136.024,143.521,148.021,152.521,156.022,158.524,162.52,166.021,168.271,170.521,177.019,181.015,184.516,191.014,195.514,200.014,204.01,206.26" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.83,0.5,0.5,0.39,0.28,0.44,0.39,0.25,0.25,0.83,0.5,0.5,0.39,0.28,0.44,0.39,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Münster, Münster, Germany, </text>
   <text y="497.583" x="208.508" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="500.103" x="211.433,217.931,222.431,225.932,228.434,234.932,239.432,243.932,246.434,250.934" svgx:width="0.72,0.5,0.39,0.28,0.72,0.5,0.5,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Dartmouth-</text>
   <text y="511.101" x="49.604,56.102,58.604,61.106,65.102,69.602,73.598,78.098,82.094,86.09,88.34,95.837,99.833,104.333,106.835,110.831,115.331,117.833,120.083,126.086,130.082,134.582,137.084,141.08,144.581,146.831,151.331,155.831,160.331,162.581,169.079,173.075,175.577,179.078,183.074,185.576,187.826,192.326,196.322,200.822,205.322,209.822,212.324,214.574,219.074,221.576,223.826,231.323,235.319,239.819,242.321,246.317,248.819,253.319,257.315" svgx:width="0.72,0.28,0.28,0.44,0.5,0.44,0.5,0.44,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.5,0.5,0.5,0.25,0.72,0.44,0.28,0.39,0.44,0.28,0.25,0.5,0.44,0.5,0.5,0.5,0.28,0.25,0.5,0.28,0.25,0.83,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Hitchcock Medical Center and Geisel School of Medicine </text>
   <text y="522.099" x="49.604,54.104,56.606,58.856,65.354,69.854,73.355,75.857,82.355,86.855,91.355,93.857,98.357,100.607,102.857,107.861,111.857,116.357,120.857,125.357,129.857,134.357,136.607,138.857,144.86,151.358,153.608,155.858,162.356,166.856,169.358,171.86,175.856,180.356,182.606,187.106,189.608,194.108,196.61,200.606,204.107,206.357" svgx:width="0.5,0.28,0.25,0.72,0.5,0.39,0.28,0.72,0.5,0.5,0.28,0.5,0.25,0.25,0.56,0.44,0.5,0.5,0.5,0.5,0.5,0.25,0.25,0.67,0.72,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">at Dartmouth, Lebanon, NH, United States, </text>
   <text y="519.583" x="208.608" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="522.103" x="211.533,218.031,222.027,228.525,232.521,235.023,239.523,244.023,248.523,251.025,254.526,257.028,261.528,265.524" svgx:width="0.72,0.44,0.72,0.44,0.28,0.5,0.5,0.5,0.28,0.39,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Gemeinnützige </text>
   <text y="533.101" x="49.605,56.103,60.099,63.6,66.102,68.604,72.6,75.597,80.097,82.599,85.101,87.603,90.105,94.605,99.105,103.605,105.855,110.355,114.855,119.355,121.605,128.103,132.603,135.105,139.101,143.097,146.598,150.099,152.601,155.103,159.099,161.349,168.846,172.842,177.342,179.844,183.84,188.34,190.842,193.092,199.095,203.091,207.591,210.093,214.089,217.59,219.84,226.338,230.838,233.34,235.842,238.344,242.844,247.344,251.34,255.84,258.09" svgx:width="0.72,0.44,0.39,0.28,0.28,0.44,0.33,0.5,0.28,0.28,0.28,0.28,0.5,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.72,0.5,0.28,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Hertie-Stiftung and University Medical Center Göttingen, </text>
   <text y="544.099" x="49.605,56.103,60.603,63.105,65.607,68.109,72.609,77.109,81.105,85.605,87.855,90.105,96.603,100.599,104.1,110.598,115.098,119.598,123.594,125.844" svgx:width="0.72,0.5,0.28,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Göttingen, Germany, </text>
   <text y="541.583" x="128.094" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="544.103" x="131.019,138.516,142.512,145.014,147.516,150.018,152.268,158.271,162.771,166.272,170.772,174.768,177.27,179.772,182.022,189.519,193.515,198.015,200.517,204.513,209.013,211.515,213.765,219.768,224.268,226.77,229.272,233.268,237.768,241.764,244.014,246.264,252.267,256.263,262.266" svgx:width="0.83,0.44,0.28,0.28,0.28,0.25,0.67,0.5,0.39,0.5,0.44,0.28,0.28,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.5,0.28,0.28,0.44,0.5,0.44,0.25,0.25,0.67,0.44,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Weill Cornell Medical College, New </text>
   <text y="555.101" x="49.605,54.609,59.109,62.61,66.606,68.856,71.106,77.109,82.113,84.363,86.613,93.111,97.611,100.113,102.615,106.611,111.111,113.361,117.861,120.363,124.863,127.365,131.361,134.862,137.112" svgx:width="0.56,0.5,0.39,0.44,0.25,0.25,0.67,0.56,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">York, NY, United States, </text>
   <text y="552.583" x="139.363" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">5</text>
   <text y="555.103" x="142.288,147.786,151.288,153.79,158.29,162.79,167.29,173.788,176.038,180.538,185.038,189.538,191.788,199.285,203.785,210.283,214.279,218.779,221.775,225.277,227.527,234.025,238.525,242.026,246.526,249.028,251.53,256.03,258.532,260.782,265.282,269.782,274.282" svgx:width="0.61,0.39,0.28,0.5,0.5,0.5,0.72,0.25,0.5,0.5,0.5,0.25,0.83,0.5,0.72,0.44,0.5,0.33,0.39,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Brigham and Women’s Hospital and </text>
   <text y="566.101" x="49.605,56.104,60.604,64.104,68.101,72.601,76.102,80.602,82.852,90.349,94.345,98.845,101.347,105.343,109.843,112.345,114.595,119.095,123.091,127.591,132.091,136.591,139.093,141.343,143.593,149.092,153.592,157.093,159.595,164.095,168.595,170.845,173.095,180.592,186.09,188.34,190.59,197.089,201.589,204.09,206.592,210.589,215.089,217.339,221.839,224.34,228.84,231.342,235.339,238.84,241.09" svgx:width="0.72,0.5,0.39,0.44,0.5,0.39,0.5,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.5,0.44,0.5,0.5,0.5,0.28,0.25,0.25,0.61,0.5,0.39,0.28,0.5,0.5,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Harvard Medical School, Boston, MA, United States, </text>
   <text y="563.583" x="243.339" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">6</text>
   <text y="566.103" x="246.264,252.762,256.758,261.258,264.759,268.755,275.253,279.249,281.499" svgx:width="0.72,0.44,0.5,0.39,0.44,0.72,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Genzyme, </text>
   <text y="577.101" x="49.605,54.105,56.355,60.855,65.355,69.855,74.355,76.857,79.359,81.609,87.612,92.112,98.61,103.11,107.61,112.11,116.106,118.356,120.606,126.105,129.606,134.106,140.604,143.106,147.606,152.106,156.606,161.106,167.604,169.854,172.104,179.601,185.1,187.35,189.6,196.098,200.598,203.1,205.602,209.598,214.098,216.348,220.848,223.35,227.85,230.352,234.348,237.849,240.099" svgx:width="0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.28,0.25,0.67,0.5,0.72,0.5,0.5,0.5,0.44,0.25,0.25,0.61,0.39,0.5,0.72,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">a Sanofi Company, Framingham, MA, United States, </text>
   <text y="574.583" x="242.349" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">7</text>
   <text y="577.103" x="245.274,249.774,254.274,258.774,263.274,265.776,268.278,270.528" svgx:width="0.5,0.5,0.5,0.5,0.28,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Sanofi, </text>
   <text y="588.101" x="49.605,55.608,60.108,62.61,65.112,67.614,71.61,74.607,82.104,86.604,90.105,94.605,98.106,100.608,105.108,107.358,109.608,115.107,118.608,123.108,127.608,131.604,135.6,137.85" svgx:width="0.67,0.5,0.28,0.28,0.28,0.44,0.33,0.83,0.5,0.39,0.5,0.39,0.28,0.5,0.25,0.25,0.61,0.39,0.5,0.5,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Chilly-Mazarin, France, </text>
   <text y="585.583" x="140.1" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">8</text>
   <text y="588.103" x="143.025,149.523,153.519,158.019,161.52,165.516,172.014,176.01,178.26,180.51,185.01,187.26,191.76,196.26,200.76,205.26,207.762,210.264,212.514,218.517,223.017,229.515,234.015,238.515,243.015,247.011,249.261,251.511,257.514,262.014,264.516,267.018,269.52,273.516" svgx:width="0.72,0.44,0.5,0.39,0.44,0.72,0.44,0.25,0.25,0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.28,0.25,0.67,0.5,0.72,0.5,0.5,0.5,0.44,0.25,0.25,0.67,0.5,0.28,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Genzyme, a Sanofi Company, Chilly-</text>
   <text y="599.101" x="49.605,57.102,61.602,65.103,69.603,73.104,75.606,80.106,82.356,84.606,90.105,93.606,98.106,102.606,106.602,110.598,112.848" svgx:width="0.83,0.5,0.39,0.5,0.39,0.28,0.5,0.25,0.25,0.61,0.39,0.5,0.5,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Mazarin, France, </text>
   <text y="596.583" x="115.099" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">9</text>
   <text y="599.103" x="118.024,125.521,130.021,134.521,137.023,140.524,144.52,149.02,151.522,153.772,159.775,163.771,168.271,171.772,176.272,178.774,183.274,187.774,190.276,194.272,198.772,201.274,203.524,206.521,211.021,214.522,217.024,219.526,222.028,226.528,229.03,233.026,235.276,237.526,245.023,249.523,254.023,256.525,260.026,264.022,268.522,271.024,273.274" svgx:width="0.83,0.5,0.5,0.28,0.39,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.25,0.83,0.5,0.5,0.28,0.39,0.44,0.5,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Montreal Neurological Institute, Montreal, </text>
   <text y="610.101" x="49.606,56.104,62.107,64.357,66.607,72.61,77.11,81.61,86.11,90.61" svgx:width="0.72,0.67,0.25,0.25,0.67,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">QC, Canada</text>
   <text y="637.101" x="49.606,55.609,60.109,64.105,69.109,73.609,77.443,81.943,86.947,91.951,96.955,99.952" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="637.101" x="101.941,106.81,110.806,113.803,116.305,119.302,121.804,126.304,130.804,135.304,142.306,144.808,149.308,153.304,155.293,157.795,161.296,163.285,167.281,169.27,173.77,178.27,182.266,186.262,189.259,193.759,197.755,200.257,202.759,207.259,209.248,213.748,216.745,220.741,223.243,225.232,227.734,234.736,241.738,246.238,250.738,255.238,262.24,266.74,271.24,275.74,278.242,282.238" svgx:width="0.61,0.44,0.33,0.28,0.33,0.28,0.5,0.5,0.5,0.78,0.28,0.5,0.44,0.25,0.28,0.39,0.25,0.44,0.25,0.5,0.5,0.44,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.25,0.5,0.33,0.44,0.28,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.78,0.5,0.5,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Teriflunomide is a once-daily oral immunomodula-</text>
   <text y="648.099" x="49.606,52.108,56.608,59.605,61.855,63.169,67.165,71.665,76.165,79.162,83.662,88.162,92.158,96.658,98.908,100.222,103.219,107.719,110.716,112.966,114.28,117.277,121.273,123.775,127.771,132.271,135.772,138.274,142.774,147.274,150.271,153.268,157.264,164.266,166.768,169.27,171.772,174.274,178.774,183.274,185.524,186.838,193.84,198.34,200.842,203.344,205.846,210.346,212.848,216.844,219.094,220.408,223.909,227.905,230.407,234.403,237.4,241.9,245.401,247.903,251.404,253.654,254.968,257.965,265.966,270.97,273.967,276.217,278.467,279.781,282.778,285.28" svgx:width="0.28,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.89,0.56,0.33,0.25,0.25,0.55,0.33,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tor approved for relapsing-remitting multiple sclerosis (MS). It </text>
   <text y="659.097" x="49.606,52.108,56.608,61.108,63.61,68.11,70.612,73.114,76.615,78.865,81.601,86.101,88.603,93.103,97.603,102.103,105.1,109.6,114.1,117.097,121.597,124.099,128.095,130.597,134.593,136.843,139.579,144.079,148.075,152.575,157.075,161.575,164.572,169.072,173.572,177.568,182.068,186.064,189.565,193.561,195.811,198.061,200.797,203.299,207.799,211.795,214.045,216.781,221.281,225.277,229.777,232.027,234.763,241.765,244.267,246.769,251.269,255.265,259.765,264.265,268.765,273.265,276.262,278.764,282.76,285.262" svgx:width="0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.39,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.33,0.5,0.28,0.44,0.28,0.44,0.25,0.55,0.5,0.44,0.5,0.5,0.5,0.33,0.5,0.5,0.44,0.5,0.44,0.39,0.44,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.78,0.28,0.28,0.5,0.44,0.5,0.5,0.5,0.5,0.33,0.28,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">inhibits dihydroorotate dehydrogenase, the key mitochondrial </text>
   <text y="670.095" x="49.606,53.602,58.102,62.098,66.598,73.6,77.596,80.053,82.555,87.055,89.512,94.012,98.008,100.474,104.974,109.474,113.974,118.474,120.931,125.431,129.931,132.928,135.43,142.432,144.934,149.434,151.936,156.436,160.432,162.889,166.39,170.89,175.39,177.892,182.392,186.388,189.889,192.391,195.892,198.349,200.851,205.351,207.817,210.814,214.81,219.31,221.812,226.312,228.814,233.314,235.771,240.271,242.773,247.273,249.775,254.275,256.777,261.277,265.777,268.234,270.736,275.236,282.238" svgx:width="0.44,0.5,0.44,0.5,0.78,0.44,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.5,0.5,0.5,0.5,0.25,0.5,0.5,0.33,0.28,0.78,0.28,0.5,0.28,0.5,0.44,0.25,0.39,0.5,0.5,0.28,0.5,0.44,0.39,0.28,0.39,0.25,0.28,0.5,0.25,0.33,0.44,0.5,0.28,0.5,0.28,0.5,0.25,0.5,0.28,0.5,0.28,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">enzyme in de novo pyrimidine synthesis in rapidly dividing lym-</text>
   <text y="681.093" x="49.606,54.106,58.606,63.106,67.102,71.602,74.104,78.1,81.601,83.851,86.101,88.603,93.103,97.603,101.104,103.354,105.856,108.358,115.36,117.862,120.364,122.866,127.366,131.866,134.116,138.616,141.613,146.113,148.615,151.117,154.114,158.11,161.107,165.103,167.605,170.107,174.607,179.107,181.357,185.857,188.854,191.104,195.1,199.096,201.598,204.1,208.6,212.596,215.098,219.094,223.594,225.844,228.346,232.846,239.848,244.348,248.848,253.348,257.344,261.844,264.346,268.342,271.843" svgx:width="0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.28,0.5,0.5,0.39,0.25,0.28,0.28,0.78,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.5,0.28,0.28,0.33,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">phocytes, thus limiting proliferation of activated lymphocytes.</text>
   <text y="692.091" x="49.606,56.608,61.612,64.609,68.605,72.601,75.598,78.1,82.6,86.596,90.097,93.094" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="692.091" x="95.263,100.132,104.632,106.801,111.301,114.298,118.294,121.795,125.791,130.291,132.793,134.962,137.464,141.964,145.96,148.129,152.629,155.626,160.126,164.626,169.126,172.627,176.623,181.123,183.292,190.294,194.29,198.286,202.786,206.782,211.282,213.784,217.285,224.287,226.456,230.956,233.953,236.122,240.118,244.114,246.616,249.118,253.618,258.118,260.287,263.284,271.285,275.785,282.283,285.28" svgx:width="0.61,0.5,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.39,0.44,0.5,0.25,0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.25,0.5,0.33,0.25,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.89,0.5,0.72,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To present the proposed mechanism of action (MoA) </text>
   <text y="703.089" x="49.606,54.106,57.103,59.353,61.855,65.851,68.848,71.35,74.347,76.849,81.349,85.849,90.349,97.351,99.853,104.353,108.349,110.599,115.099,119.095,122.596,126.592,131.092,133.342,137.842,142.342" svgx:width="0.5,0.33,0.25,0.28,0.44,0.33,0.28,0.33,0.28,0.5,0.5,0.5,0.78,0.28,0.5,0.44,0.25,0.5,0.44,0.39,0.44,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of teriflunomide based on </text>
   <text y="703.089" x="144.592,147.094,151.594,153.844,157.84,160.342,162.844,166.012" svgx:width="0.28,0.5,0.25,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vitro</text>
   <text y="703.089" x="170.512,172.762,175.012,179.512,182.509,186.505,190.501,193.003,195.505,200.005,202.507,206.503,210.499,213.001,215.251,219.247,223.747,228.247,230.497,234.493,236.995,239.497,243.997,246.499,250.495,254.491,256.993,259.243,263.743,267.739,270.241,274.237" svgx:width="0.25,0.25,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, preclinical and clinical data.</text>
   <text y="714.087" x="49.606,58.102,62.098,65.095,70.099,74.599,79.603,83.104,86.101" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="714.087" x="88.54,94.039,98.539,102.535,104.974,107.971,112.471,114.973,117.475,121.975,128.473,130.975,135.475,139.975,142.414,148.912,152.908,155.905,159.901,162.34,166.336,170.836,174.832,177.334,181.834,185.83,189.826,194.326,196.828" svgx:width="0.61,0.5,0.44,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.28,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The following were analyzed: </text>
   <text y="714.087" x="199.267,201.769,206.269,208.708,212.704,215.206,217.708,220.876" svgx:width="0.28,0.5,0.25,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vitro</text>
   <text y="714.087" x="225.376,227.815,232.315,236.815,243.817,247.813,252.313,254.752,257.254,261.754,268.756,273.256,277.756,282.256" svgx:width="0.25,0.5,0.5,0.78,0.44,0.5,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> human lympho-</text>
   <text y="725.085" x="49.606,53.602,58.102,60.604,64.6,66.877,71.377,74.374,78.874,81.376,83.878,86.875,90.871,93.868,97.864,100.366,102.868,107.368,111.868,114.145,118.141,122.641,127.141,129.418,133.918,136.42,140.416,144.916,147.418,149.92,152.422,154.924,159.424,161.926" svgx:width="0.44,0.5,0.28,0.44,0.25,0.5,0.33,0.5,0.28,0.28,0.33,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cyte proliferation and viability; </text>
   <text y="725.085" x="164.203,166.705,171.205,173.482,177.478,179.98,182.482,185.65" svgx:width="0.28,0.5,0.25,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vitro</text>
   <text y="725.085" x="190.15,192.427,199.429,203.929,208.429,211.93,215.926,218.041,222.712,225.709,229.705,233.701,236.203,238.705,240.982,243.979,247.975,251.476,255.976,260.476,264.976,268.477,272.473,275.974,278.251,280.753,285.253" svgx:width="0.25,0.78,0.5,0.5,0.39,0.44,0.25,0.61,0.33,0.44,0.44,0.28,0.28,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> mouse T-cell responses to </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M297.260 501.300 L347.990 501.300 "/>
  <g begin="text">
   <text y="77.103" x="297.26,301.256,305.756,310.256,314.756,318.752,321.254,325.25,327.779,332.279,336.275,340.775,343.277,345.779,350.279,354.275,356.804,361.304,365.3,368.297,370.799,374.795,379.295,381.797,385.298,387.827,390.329,394.829,397.358,399.86,404.36,408.356,410.885,415.385,418.382,422.378,425.879,429.875,434.375,438.371,442.367,444.869,448.865,453.365,456.866,460.862,465.362,469.358,473.354,475.883,480.383,483.38,485.909,490.409,494.405,497.402,499.904,504.404,508.904,512.405,514.934,517.436,521.432,524.429,526.931,529.928" svgx:width="0.44,0.5,0.5,0.5,0.44,0.28,0.44,0.25,0.5,0.44,0.5,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.33,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.28,0.44,0.5,0.39,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.39,0.25,0.28,0.44,0.33,0.28,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cognate peptide variants in the presence/absence of various terif-</text>
   <text y="88.101" x="297.26,299.762,304.262,308.762,313.262,320.264,322.766,327.266,331.262,333.512,335.141,339.137,343.637,348.137,352.133,356.129,360.629,363.131,366.128,370.124,372.626,375.128,379.628,384.128,387.629,390.131,392.381,394.01,396.512,400.508,403.505,406.007,409.004,411.506,416.006,420.506,425.006,432.008,434.51,439.01,443.006,445.256,446.885,449.387,456.389,460.889,464.885,468.881,471.383,473.633,475.271,477.773,482.273,484.523,486.152,490.148,492.398,494.036,497.033,501.029,503.531,505.781,507.41,511.406,515.906,520.406,524.402,527.399,529.901" svgx:width="0.28,0.5,0.5,0.5,0.78,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.39,0.28,0.25,0.55,0.28,0.44,0.33,0.28,0.33,0.28,0.5,0.5,0.5,0.78,0.28,0.5,0.44,0.25,0.55,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.33,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.44,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lunomide concentrations; teriflunomide impact in a rat experi-</text>
   <text y="99.099" x="297.26,304.262,308.258,312.758,315.26,319.256,321.758,324.008,326.897,330.893,335.393,337.895,342.395,344.897,351.899,358.901,363.401,367.901,371.897,374.147,377.036,381.032,385.532,389.528,393.524,398.024,402.524,406.52,409.022,413.522,420.524,425.024,429.02,431.522,434.024,436.526,439.028,442.529,444.779,447.668,450.665,456.164,462.662,468.161,471.158,473.408,476.297,483.299,487.799,492.299,496.295,498.797,501.047,503.936,506.933,511.433,513.935,517.436,521.432,525.428,528.929,532.925" svgx:width="0.78,0.44,0.5,0.28,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.33,0.61,0.72,0.61,0.33,0.25,0.55,0.78,0.5,0.5,0.44,0.28,0.25,0.55,0.33,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mental autoimmune encephalomyelitis (EAE) model (disease </text>
   <text y="110.097" x="297.26,300.761,304.757,309.257,313.253,316.25,318.752,321.254,325.169,327.419,329.669,330.38,334.376,338.372,342.872,345.374,348.371,352.367,354.869,357.119,357.839,362.339,366.335,369.332,373.832,378.332,382.832,386.333,388.583,389.294,392.795,397.295,400.796,403.298,407.294,414.296,416.546,417.257,420.254,426.257,432.755,437.759,440.756,443.006,443.717,446.219,453.221,460.223,464.723,469.223,473.219,475.469,476.189,480.185,484.181,486.683,489.185,491.435,492.146,494.648,499.148,502.145,504.647,507.149,509.651,512.648,516.644,519.146,521.648,526.148,530.648,532.898" svgx:width="0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.25,0.55,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.55,0.5,0.44,0.33,0.5,0.5,0.5,0.39,0.25,0.55,0.39,0.5,0.39,0.28,0.44,0.78,0.25,0.55,0.33,0.67,0.72,0.56,0.33,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.28,0.5,0.33,0.28,0.28,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">severity, central nervous system [CNS] immune cell infiltration, </text>
   <text y="121.095" x="297.26,301.76,305.756,310.256,313.253,317.753,322.253,326.249,328.751,330.713,334.709,339.209,343.709,348.209,352.709,356.705,359.207,361.709,366.209,370.709,373.706,376.208,378.17,382.166,386.666,389.168,391.67,396.17,400.67,405.17,409.67,411.632,414.629,418.625,422.126,426.626,431.126,435.626,439.127,443.123,446.624,448.586,451.088,455.588,457.55,464.552,467.054,471.05,475.046,477.008,481.004,485.504,490.004,491.966,494.468,498.968,500.93,503.432,509.93,514.43,516.392,520.388,522.89,525.392,529.892" svgx:width="0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.33,0.28,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.28,0.5,0.25,0.78,0.28,0.44,0.44,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.72,0.5,0.25,0.44,0.28,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">neuronal conduction); antibody responses in mice and in two clin-</text>
   <text y="132.093" x="297.26,299.762,303.758,307.754,310.256,312.506,316.007,318.509,323.009,327.509,330.011,334.007,337.508,340.01,342.26,346.256,350.756,355.256,357.506,362.006,364.508,369.008,373.508,376.01,380.006,382.508,384.758,388.754,391.256,393.758,398.258,400.76,404.756,408.752,411.254,413.504,416.006,419.003,421.505,425.501,428.003,431.504,433.754,436.256,440.756,443.006,447.506,451.502,454.004,456.506,460.502,465.002,467.504,471.005,473.255,479.753,482.255,484.757,489.257,491.507,499.508,504.512" svgx:width="0.28,0.44,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.28,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.5,0.28,0.44,0.28,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ical studies; and pivotal clinical trials in patients with MS.</text>
   <text y="143.091" x="297.26,303.893,308.024,311.66,316.799,319.436,322.568,326.204,329.336" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="143.091" x="331.127,334.259,338.894,340.685,344.816,347.453,350.09,353.393" svgx:width="0.33,0.5,0.25,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">In vitro</text>
   <text y="143.091" x="358.028,360.413,362.204,364.841,368.972,372.104,374.741,377.873,380.51,385.145,389.78,394.415,401.552,404.189,408.824,412.955,414.746,417.383,422.018,426.653,429.29,433.925,436.562,439.199,443.33,447.965,449.756,454.391,457.523,462.158,464.795,467.432,470.564,474.695,477.827,481.958,484.595,487.232,491.867,496.502,498.293,502.928,506.06,507.851,512.486,517.121,524.258,528.389,532.889" svgx:width="0.25,0.25,0.28,0.44,0.33,0.28,0.33,0.28,0.5,0.5,0.5,0.78,0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.33,0.5,0.28,0.28,0.33,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, teriflunomide inhibited proliferation of human </text>
   <text y="154.089" x="297.26,302.732,304.982,305.972,310.103,314.738,319.373,321.623,322.613,328.751,331.001,331.991,336.122,340.253,342.89,345.527,349.163,351.413,352.403,356.039,358.676,361.313,368.45,373.085,375.722,379.853,382.49,386.621,391.256,393.506,394.496,401.129,403.766,406.403,411.038,413.288,414.278,418.409,423.044,425.681,428.318,431.45,437.588,444.221,448.856,451.106,452.096,456.731,459.863,462.113,463.103,469.241,473.876,480.509,482.894,485.144,486.134,489.266,493.397,497.033,501.668,505.799,509.93,512.567,515.204,519.839,523.97,526.607,530.657,532.907" svgx:width="0.61,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.67,0.72,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.5,0.72,0.25,0.25,0.55,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">T and B cells stimulated with anti-CD3 or CpG, respectively, </text>
   <text y="165.087" x="297.26,301.391,306.026,310.661,312.983,316.619,319.256,322.388,327.023,331.658,336.293,338.93,343.565,345.887,348.524,353.159,357.794,360.431,365.066,367.703,370.34,374.471,379.106,381.428,386.063,389.195,393.83,396.467,399.104,402.236,406.367,409.499,413.63,416.267,418.904,423.539,428.174,430.496,435.131,438.263,440.585,447.722,452.357,456.992,460.628,464.759,466.919,472.391,474.713,478.844,482.975,485.612,488.249,491.885,494.207,497.843,500.48,503.117,510.254,514.889,517.526,521.657,524.294,528.425,532.925" svgx:width="0.44,0.5,0.5,0.25,0.39,0.28,0.33,0.5,0.5,0.5,0.28,0.5,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.33,0.5,0.28,0.28,0.33,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.78,0.5,0.5,0.39,0.44,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and strongly inhibited proliferation of mouse T cells stimulated </text>
   <text y="176.085" x="297.26,303.893,306.53,309.167,313.802,316.052,317.06,321.695,324.332,328.967,333.602,336.734,340.865,343.835,346.967,349.604,354.239,356.876,359.513,364.148,366.398,367.406,372.041,376.172,380.807,383.444,386.081,390.716,394.847,398.483,401.12,403.37,404.378,407.015,409.652,411.902,412.919,417.554,421.685,426.32,428.57,429.578,434.213,438.848,441.098,442.106,444.743,451.88,456.515,460.646,464.777,467.414,469.664,470.681,475.316,479.951,482.201,483.209,487.34,491.471,494.108,496.745,498.995,500.003,504.638,507.275,511.406,516.041,518.678,521.315,523.952,526.589,530.639,532.889" svgx:width="0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.33,0.44,0.33,0.33,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.5,0.28,0.28,0.5,0.44,0.39,0.28,0.25,0.55,0.28,0.28,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.5,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with high-affinity peptides; it had no impact on cell viability. </text>
   <text y="187.083" x="297.26,302.264,306.395,309.527,312.164,315.296,317.933,322.568,327.203,331.838,338.975,341.612,346.247,350.378,353.51,356.147,359.279,363.41,367.541,370.178,374.309,378.944,381.185,386.819,393.452,399.086,401.327,404.459,408.59,411.227,414.863,417.104,421.739,425.87,430.505,432.746,435.878,440.009,444.644,449.279,453.41,457.541,462.176,464.417,470.555,477.188,482.327,484.406,489.212,492.344,494.585,498.716,503.351,507.986,510.227,516.365,519.497,523.628,527.759,530.396,532.898" svgx:width="0.61,0.44,0.33,0.28,0.33,0.28,0.5,0.5,0.5,0.78,0.28,0.5,0.44,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.61,0.72,0.61,0.25,0.33,0.44,0.28,0.39,0.25,0.5,0.44,0.5,0.25,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.67,0.72,0.56,0.25,0.61,0.33,0.25,0.44,0.5,0.5,0.25,0.67,0.33,0.44,0.44,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Teriflunomide-treated EAE rats had reduced CNS T- and B-cell </text>
   <text y="198.081" x="297.26,299.897,304.532,307.664,310.301,312.938,315.575,318.707,322.838,325.475,328.112,332.747,337.382,339.767,342.017,343.961,347.093,351.224,355.859,360.494,364.625,368.756,373.391,375.641,377.585,382.22,384.857,388.493,392.624,396.755,400.391,404.522,406.772,408.716,412.352,416.483,421.118,425.249,428.381,431.018,433.655,438.29,440.54,442.484,446.615,451.25,455.885,458.135,460.079,464.714,467.846,471.977,475.613,479.744,482.876,487.511,491.642,496.277,498.527,500.471,505.106,509.237,513.872,517.004,521.639,526.274,530.405,532.907" svgx:width="0.28,0.5,0.33,0.28,0.28,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.55,0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">infiltration, reduced disease severity and preserved neuronal </text>
   <text y="209.079" x="297.26,301.391,306.026,310.661,315.296,319.931,324.062,326.699,329.336,333.971,338.606,340.856,341.531,344.168,348.803,351.053,351.728,355.364,359.999,367.136,371.267,373.904,378.539,382.175,386.306,390.941,394.577,399.212,402.344,406.979,409.229,409.904,414.035,418.67,423.305,425.555,426.23,433.367,438.002,440.639,445.274,448.406,450.656,451.331,453.968,457.1,461.231,465.362,467.999,471.635,474.02,476.783,481.787,485.918,489.05,491.687,494.819,497.456,502.091,506.726,511.361,518.498,521.135,525.77,529.901" svgx:width="0.44,0.5,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.39,0.5,0.78,0.44,0.28,0.5,0.39,0.44,0.5,0.39,0.5,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.5,0.33,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.39,0.25,0.25,0.61,0.44,0.33,0.28,0.33,0.28,0.5,0.5,0.5,0.78,0.28,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">conduction in somatosensory and motor tracts. Teriflunomide-</text>
   <text y="220.077" x="297.26,299.897,303.029,307.16,311.291,313.928,318.059,322.694,324.944,327.653,334.79,337.427,341.558,345.689,347.939,350.648,355.283,359.414,364.049,368.18,370.817,375.452,380.087,384.218,388.853,391.103,393.812,397.943,400.913,404.045,408.176,412.307,414.944,417.581,422.216,426.347,428.597,431.306,435.941,440.576,443.213,445.463,448.172,451.808,454.445,457.082,461.717,466.352,468.989,471.626,476.261,478.511,481.22,485.855,489.986,492.623,496.754,501.389,505.52,510.155,512.405,515.114,518.246,523.457,525.707,528.416,532.916" svgx:width="0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.78,0.28,0.44,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.39,0.28,0.28,0.5,0.5,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.33,0.56,0.25,0.55,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treated mice developed effective but slightly delayed (&lt; 2 </text>
   <text y="231.075" x="297.26,303.893,308.024,312.155,316.79,320.426,323.558,325.925,333.062,337.193,344.33,348.965,352.097,356.732,359.099,363.23,367.865,372.5,374.867,379.502,382.634,385.271,392.408,396.539,399.671,404.306,406.673,410.804,415.439,418.076,420.713,425.348,429.983,434.618,439.253,441.62,444.752,448.883,452.519,457.154,461.789,466.424,470.06,474.191,477.827,480.194,482.831,487.466,489.833,493.964,498.599,502.73,507.365,512.0,516.635,519.272,522.404,527.039,530.675,532.925" svgx:width="0.72,0.44,0.44,0.5,0.39,0.33,0.25,0.78,0.44,0.78,0.5,0.33,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.28,0.78,0.44,0.33,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.28,0.5,0.25,0.44,0.5,0.44,0.5,0.5,0.5,0.28,0.33,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">weeks) memory and primary antibody responses to adenovirus. </text>
   <text y="242.073" x="297.26,302.264,306.395,309.527,312.164,315.296,317.933,322.568,327.203,331.838,338.975,341.612,346.247,350.378,353.51,356.147,359.279,363.41,367.541,370.178,374.309,378.944,381.194,384.992,389.627,393.758,396.395,399.032,403.163,407.798,410.435,414.071,416.321,420.119,426.752,429.389,432.026,436.661,438.911,442.709,450.845,455.984,458.234,462.032,469.169,473.804,478.439,483.074,485.711,489.842,494.477,496.727,500.525,504.656,507.626,510.758,514.889,519.02,521.657,524.294,528.929,532.925" svgx:width="0.61,0.44,0.33,0.28,0.33,0.28,0.5,0.5,0.5,0.78,0.28,0.5,0.44,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.78,0.5,0.5,0.5,0.28,0.44,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Teriflunomide-treated patients with MS mounted effective </text>
   <text y="253.071" x="297.26,304.397,308.528,315.665,320.3,323.432,328.067,330.317,340.109,343.241,347.372,351.008,355.643,360.278,364.913,368.549,372.68,376.316,378.566,388.358,390.995,395.63,397.88,407.672,410.309,414.944,418.076,420.713,425.348,429.479,434.114,438.245,442.376,444.626,454.418,459.053,463.184,467.315,471.446,474.083,478.718,482.849,485.099,494.891,498.023,503.657,509.291,515.429,518.561,524.033,530.666,532.916" svgx:width="0.78,0.44,0.78,0.5,0.33,0.5,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.33,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.44,0.44,0.44,0.28,0.5,0.44,0.25,0.55,0.33,0.61,0.61,0.67,0.33,0.72,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">memory responses to influenza vaccine (TERIVA, </text>
   <text y="264.069" x="297.26,303.893,310.031,315.665,320.3,324.935,329.57,334.205,338.84,343.475,348.11,352.745,355.877,358.262,360.512,365.336,369.467,374.102,378.737,380.987,385.811,388.448,392.579,395.711,398.348,401.48,404.117,408.752,413.387,418.022,425.159,427.796,432.431,436.562,439.694,444.329,448.964,452.6,456.731,461.366,463.616,468.44,473.075,477.206,481.337,483.974,486.611,491.246,495.881,498.131,502.955,506.591,511.226,515.861,518.498,522.629,526.76,529.397,532.898" svgx:width="0.72,0.67,0.61,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.44,0.33,0.28,0.33,0.28,0.5,0.5,0.5,0.78,0.28,0.5,0.44,0.33,0.5,0.5,0.39,0.44,0.5,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NCT01403376), and teriflunomide-dosed healthy subjects </text>
   <text y="275.067" x="297.26,304.397,308.528,313.163,317.294,319.643,323.279,327.41,330.542,335.177,339.812,342.944,347.579,350.216,354.347,358.478,361.115,363.752,368.387,372.518,374.867,378.998,383.633,386.27,388.907,393.542,398.177,402.812,407.447,409.796,412.928,417.059,420.695,425.33,429.965,434.6,438.236,442.367,446.003,448.352,450.989,455.624,457.973,461.105,465.236,469.871,472.508,476.639,480.275,482.624,487.259,491.39,495.521,499.652,502.289,506.924,511.055,513.404,516.536,521.171,525.302,529.937" svgx:width="0.78,0.44,0.5,0.44,0.25,0.39,0.44,0.33,0.5,0.5,0.33,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.28,0.5,0.25,0.33,0.44,0.5,0.28,0.44,0.39,0.25,0.5,0.44,0.44,0.44,0.28,0.5,0.44,0.25,0.33,0.5,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">made seroprotective antibody responses to rabies vaccine (neo-</text>
   <text y="286.065" x="297.26,301.391,306.026,308.663,311.3,315.935,320.066,324.701,327.833,330.218,332.468,333.917,338.048,340.685,345.32,349.451,352.088,354.725,356.975,358.424,362.555,365.192,367.442,368.9,371.537,376.172,382.805,386.936,390.068,392.318,393.767,396.404,399.041,401.678,405.809,408.941,412.577,414.827,416.276,418.913,423.548,427.679,432.314,434.564,436.022,438.659,443.294,447.929,451.565,455.696,457.946,459.404,464.039,466.676,471.311,475.442,480.077,482.327,483.776,488.411,491.048,495.179,499.31,503.441,508.076,512.711,515.096,517.346,518.642,524.276,528.911,532.907" svgx:width="0.44,0.5,0.28,0.28,0.5,0.44,0.5,0.33,0.25,0.25,0.55,0.44,0.28,0.5,0.44,0.28,0.28,0.25,0.55,0.44,0.28,0.25,0.55,0.28,0.5,0.72,0.44,0.33,0.25,0.55,0.28,0.28,0.28,0.44,0.33,0.39,0.25,0.55,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.5,0.39,0.44,0.25,0.55,0.5,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">antigen), albeit at lower titers than those given placebo. The </text>
   <text y="297.063" x="297.26,302.894,308.528,316.664,321.803,328.436,330.686,331.748,334.88,341.513,347.651,353.285,357.92,362.555,367.19,371.825,376.46,381.095,385.73,390.365,393.497,395.747,396.809,400.94,405.575,410.21,412.46,413.36,418.832,425.465,434.096,439.73,445.868,448.118,449.18,452.312,458.945,465.083,470.717,475.352,479.987,484.622,489.257,493.892,498.527,503.162,507.797,510.929,513.179,514.241,516.878,520.01,522.647,526.778,529.415,532.916" svgx:width="0.61,0.61,0.89,0.56,0.72,0.25,0.55,0.33,0.72,0.67,0.61,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.72,0.94,0.61,0.67,0.25,0.55,0.33,0.72,0.67,0.61,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.28,0.33,0.28,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">TEMSO (NCT00134563) and TOWER (NCT00751881) trials </text>
   <text y="308.061" x="297.26,300.896,305.531,310.166,316.799,320.93,325.565,327.815,329.453,333.089,335.726,340.361,344.996,347.633,350.765,353.402,357.533,361.664,366.299,368.936,371.186,372.824,377.459,381.59,385.721,388.853,392.984,397.115,400.751,404.882,408.518,410.768,412.406,415.043,419.678,421.928,423.566,427.697,432.332,436.967,441.602,445.733,448.37,451.007,455.138,459.269,463.904,466.154,467.792,470.924,475.055,477.692,481.823,486.458,490.094,494.225,496.475,498.113,501.245,505.376,508.013,512.144,515.78,518.03,519.668,523.799,528.434,532.934" svgx:width="0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.44,0.28,0.28,0.44,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.55,0.33,0.44,0.28,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">showed significant decreases in annualized relapse rates and </text>
   <text y="319.059" x="297.26,303.398,310.031,315.17,317.105,319.742,323.873,327.509,330.146,334.781,339.416,341.351,345.482,349.613,353.744,358.379,365.516,370.151,372.788,376.919,379.556,382.193,386.828,391.463,393.398,396.53,402.164,407.798,415.934,421.073,427.706,429.641,434.276,438.911,441.548,446.183,448.82,450.755,455.39,460.025,462.662,464.597,467.234,471.365,475.001,477.638,481.769,486.404,488.339,490.976,495.611,497.384,502.856,509.489,518.12,523.754,529.892,532.889" svgx:width="0.67,0.72,0.56,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.25,0.44,0.44,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.61,0.61,0.89,0.56,0.72,0.25,0.5,0.5,0.28,0.5,0.28,0.25,0.5,0.5,0.28,0.25,0.28,0.44,0.39,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.61,0.72,0.94,0.61,0.67,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CNS lesion accumulation (TEMSO only; not tested in TOWER) </text>
   <text y="330.057" x="297.26,301.895,305.531,308.069,312.704,315.341,319.472,323.603,327.734,332.369,337.004,339.389,341.927,346.058,350.693,355.328,358.964,361.601,365.237,367.874,372.005,376.64,379.277,381.815,388.448,391.085,393.722,398.357,400.895,405.026,409.661,412.199,416.33,420.965,423.602,426.239,429.371,432.008,436.643,439.775,442.412,446.543,453.68,460.817,464.948,467.585,472.22,475.352,479.987,482.525,490.661,495.296,501.434,503.972,507.104,511.739,514.871,517.409,520.046,524.177,527.309,529.946" svgx:width="0.5,0.39,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.25,0.44,0.5,0.5,0.39,0.28,0.39,0.28,0.44,0.5,0.28,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.5,0.25,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.89,0.5,0.72,0.25,0.33,0.5,0.33,0.25,0.28,0.44,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">vs placebo, consistent with an anti-inflammatory MoA for teri-</text>
   <text y="341.055" x="297.26,300.392,303.029,307.664,312.299,316.934,324.071,326.708,331.343,335.474,337.859,340.109,341.567,347.201,351.836,355.967,359.099,363.23,365.48,367.1,373.733,377.864,381.5,383.75,385.37,390.005,394.64,396.89,398.51,402.641,407.276,409.913,414.548,418.679,423.314,427.445,431.576,433.826,435.446,440.081,443.213,445.463,447.083,449.72,456.857,463.994,468.629,473.264,477.899,481.535,486.17,490.805,495.44,498.572,502.703,506.339,509.975,512.612,517.247,521.882,524.132,525.752,528.389,532.889" svgx:width="0.33,0.28,0.5,0.5,0.5,0.78,0.28,0.5,0.44,0.25,0.25,0.55,0.61,0.5,0.44,0.33,0.44,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">flunomide. There was no evidence of immunosuppression in </text>
   <text y="352.053" x="297.26,302.894,308.528,316.664,321.803,328.436,330.821,333.071,334.133,336.77,339.407,343.043,345.293,346.355,350.486,355.121,357.758,361.889,366.524,370.16,372.797,377.432,382.067,384.317,385.379,388.511,395.144,401.282,406.916,411.551,416.186,420.821,425.456,430.091,434.726,439.361,443.996,447.128,449.378,450.44,455.075,458.207,460.457,461.357,466.829,473.462,482.093,487.727,493.865,496.502,498.752,499.814,502.451,507.086,510.218,514.349,518.48,521.117,523.754,528.389,532.889" svgx:width="0.61,0.61,0.89,0.56,0.72,0.25,0.25,0.55,0.28,0.28,0.39,0.25,0.55,0.44,0.5,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.33,0.72,0.67,0.61,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.72,0.94,0.61,0.67,0.28,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">TEMSO, its extension (NCT00803049) or TOWER; infection </text>
   <text y="363.051" x="297.26,301.391,306.026,310.661,313.361,320.498,324.629,327.266,329.903,334.538,339.173,343.304,347.939,352.07,356.705,359.405,362.537,366.668,369.305,373.436,377.072,379.772,386.405,390.536,393.668,397.799,400.499,404.135,406.772,413.909,416.546,419.183,423.314,426.446,429.146,431.783,436.418,439.118,443.753,446.39,450.521,454.652,458.783,463.418,468.053,470.438,473.138,481.274,485.405,489.536,494.171,496.871,499.508,503.639,508.274,512.909,517.544,521.675,526.31,528.947,532.943" svgx:width="0.44,0.5,0.5,0.25,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.33,0.44,0.28,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.28,0.5,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.25,0.89,0.44,0.44,0.5,0.25,0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and malignancy rates were similar to placebo. Mean leukocyte </text>
   <text y="374.049" x="297.26,301.391,306.026,310.661,315.296,317.933,321.569,324.359,330.992,335.123,338.255,342.386,345.176,348.308,352.439,357.074,361.709,365.84,369.971,374.606,377.396,382.031,386.666,389.456,394.667,397.457,402.092,406.727,414.359,417.149,420.281,423.413,428.048,435.185,437.975,442.61,446.741,450.377,454.508,457.145,459.782,464.417,468.548,470.933,473.723,478.358,482.993,485.63,488.42,491.552,495.683,502.82,506.951,509.588,514.223,518.354,522.989,525.779,528.416,532.916" svgx:width="0.44,0.5,0.5,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.56,0.25,0.5,0.5,0.83,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.5,0.5,0.28,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">counts were reduced by &lt; 15% from baseline, but remained in </text>
   <text y="385.047" x="297.26,299.897,304.532,308.663,311.048,315.683,320.318,323.45,330.587,334.718,337.355,339.74,342.872,347.003,351.638,356.273,360.404" svgx:width="0.28,0.5,0.44,0.25,0.5,0.5,0.33,0.78,0.44,0.28,0.25,0.33,0.44,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the normal range.</text>
   <text y="396.045" x="297.26,303.758,308.258,313.262,317.258,319.76,324.764,328.265,330.767,335.267,340.271,343.772,346.769" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="396.045" x="349.523,354.392,358.388,361.385,363.887,366.884,369.386,373.886,378.386,382.886,389.888,392.39,396.89,400.886,403.64,410.642,415.142,419.642,424.142,426.644,430.64,433.142,437.138,440.639,443.393,445.895,452.897,459.899,464.399,468.899,471.401,473.903,478.403,481.157,483.659,488.159,491.156,495.656,500.156,504.656,509.156,511.91,515.411,519.407,521.909,525.905,529.901" svgx:width="0.61,0.44,0.33,0.28,0.33,0.28,0.5,0.5,0.5,0.78,0.28,0.5,0.44,0.25,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.44,0.39,0.25,0.28,0.78,0.78,0.5,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.39,0.44,0.28,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Teriflunomide modulates immunity through selec-</text>
   <text y="407.043" x="297.26,299.762,302.264,306.764,310.76,313.262,317.762,320.012,322.01,324.512,329.012,333.512,336.014,340.514,343.016,345.518,348.02,352.52,357.02,359.27,361.268,365.768,368.765,373.265,375.767,378.269,381.266,385.262,388.259,392.255,394.757,397.259,401.759,406.259,408.509,410.507,415.007,418.004,420.254,422.252,426.248,430.244,432.746,435.248,439.748,443.744,446.246,450.242,454.742,456.992,458.828,464.165,466.415,468.413,472.409,476.909,481.409,483.659,485.657,491.66,493.91,495.908,499.904,503.9,506.402,508.904,512.405,514.655,516.905,518.903,525.401,529.901,532.898" svgx:width="0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.28,0.28,0.33,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.61,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.72,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tively inhibiting proliferation of activated T and B cells. Our </text>
   <text y="418.041" x="297.26,301.76,306.26,309.761,313.757,316.754,321.254,325.25,327.752,330.254,334.754,339.254,342.755,344.78,349.28,352.277,356.777,361.277,363.779,368.279,372.275,374.3,376.802,381.302,384.803,387.305,391.805,396.305,398.807,400.823,403.325,407.825,410.327,414.827,416.852,419.354,423.854,427.85,429.875,436.877,440.873,444.869,449.369,453.365,457.865,460.367,463.868,470.87,472.886,477.386,481.886,483.911,490.409,494.909,497.411,501.407,505.907,507.932,510.434,514.43,517.427,519.929,522.926,525.428,529.928" svgx:width="0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.33,0.5,0.5,0.28,0.5,0.44,0.25,0.28,0.5,0.39,0.28,0.5,0.5,0.28,0.25,0.28,0.5,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.25,0.5,0.5,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.28,0.44,0.33,0.28,0.33,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">observations provide insight into the mechanism by which teriflu-</text>
   <text y="429.039" x="297.26,301.76,306.26,313.262,315.764,320.264,324.26,327.077,329.579,332.576,336.572,340.568,343.07,350.072,354.068,358.568,361.07,363.887,366.884,370.88,375.38,379.88,383.876,387.872,391.373,394.19,398.69,401.192,404.693,408.689,412.685,416.186,420.182,422.999,426.5,430.496,434.996,438.992,441.989,444.491,446.993,451.493,454.31,460.808,465.308,467.81,470.312,474.308,477.125,481.625,484.622,488.618,492.119,496.115,499.112,503.612,506.114,510.614,515.114,517.931,522.431,525.428,529.928" svgx:width="0.5,0.5,0.78,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.33,0.44,0.5,0.5,0.44,0.44,0.39,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.72,0.5,0.28,0.28,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.33,0.5,0.28,0.5,0.5,0.25,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nomide treatment reduces disease severity while preserving pro-</text>
   <text y="440.037" x="297.26,299.762,303.758,307.754,310.256,312.758,317.258,321.254,323.504,326.006,333.008,340.01,344.51,349.01,351.512,354.014,358.514,360.764,363.266,367.766,370.016,374.516,378.512,381.014,383.516,387.512,392.012,394.514,398.015,400.265,406.763,409.265,411.767,416.267,418.517,426.518,431.522" svgx:width="0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.78,0.78,0.5,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tective immunity in patients with MS.</text>
   <text y="467.037" x="297.26,302.759,307.259,311.759" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P960</text>
   <text y="478.035" x="297.26,303.263,308.267,313.271,317.771,322.775,326.771,330.767,335.771,338.021,342.521,347.021,351.521,356.525,361.025,363.527,365.777,373.274,377.27,380.267,384.767,389.771,394.271,396.773,399.275,402.776,410.273,412.523,415.025,420.029,422.279,429.776,434.78,437.282,440.279,442.781,447.785,450.287,454.283,456.533,460.034,464.03,466.532,470.528,474.524,479.024,482.525,485.027,488.528" svgx:width="0.67,0.56,0.56,0.5,0.56,0.44,0.44,0.56,0.25,0.5,0.5,0.5,0.56,0.5,0.28,0.25,0.83,0.44,0.33,0.5,0.56,0.5,0.28,0.28,0.39,0.83,0.25,0.28,0.56,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Enhanced axonal metabolism in multiple sclerosis </text>
   <text y="489.033" x="297.26,302.264,306.764,309.761,312.263,316.259,321.263,324.26,327.761,330.011,333.008,337.004,341.0,345.5,348.497,352.493,357.497,359.747,366.245,368.747,371.744,376.748,378.998,384.002,388.502,391.499,395.999,398.501,401.003,404.999,410.003,417.5,422.0" svgx:width="0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.33,0.44,0.44,0.5,0.33,0.44,0.56,0.25,0.72,0.28,0.33,0.56,0.25,0.56,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">patients treated with natalizumab</text>
   <text y="500.031" x="297.26,303.758,309.257,311.507,320.003,322.505,326.501,331.001,334.997,339.497,343.997" svgx:width="0.72,0.61,0.25,0.94,0.28,0.44,0.5,0.44,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">OT Wiebenga</text>
   <text y="497.583" x="347.992,350.917,352.38" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1,2</text>
   <text y="500.103" x="355.305,357.555,359.805,366.303,374.304,376.554,383.052,385.554,389.55,394.05,397.551,401.547" svgx:width="0.25,0.25,0.72,0.89,0.25,0.72,0.28,0.44,0.5,0.39,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, AM Klauser</text>
   <text y="497.583" x="404.543" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="500.103" x="407.468,409.718,411.968,419.969,427.97,430.22,435.224,439.22,443.72,448.22,452.72,457.22,461.72,465.716,468.218" svgx:width="0.25,0.25,0.89,0.89,0.25,0.56,0.44,0.5,0.5,0.5,0.5,0.5,0.44,0.28,0.78" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MM Schoonheim</text>
   <text y="497.583" x="475.219" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="500.103" x="478.144,480.394,482.644,489.142,492.643,499.141" svgx:width="0.25,0.25,0.72,0.39,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, GJA </text>
   <text y="511.101" x="297.262,303.76,307.756,312.256,314.758,318.754,323.254,327.25,331.246" svgx:width="0.72,0.44,0.5,0.28,0.44,0.5,0.44,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Nagtegaal</text>
   <text y="508.583" x="333.745,336.67,338.133" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1,2</text>
   <text y="511.103" x="341.058,343.308,345.558,353.559,360.057,362.307,367.311,369.813,373.809,377.805,382.305,388.803,391.305,393.807" svgx:width="0.25,0.25,0.89,0.72,0.25,0.56,0.28,0.44,0.44,0.5,0.72,0.28,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MD Steenwijk</text>
   <text y="508.583" x="398.306" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="511.103" x="401.231,403.481,405.731,409.232,415.73,417.98,422.48,426.476,430.976,433.226,439.229,443.729,447.23,450.731,455.231" svgx:width="0.25,0.25,0.39,0.72,0.25,0.5,0.44,0.5,0.25,0.67,0.5,0.39,0.39,0.5,0.78" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, JA van Rossum</text>
   <text y="508.583" x="462.233" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="511.103" x="465.158,467.408,469.658,475.66,482.158,484.408,489.412,493.912,496.414,503.417,507.413" svgx:width="0.25,0.25,0.67,0.72,0.25,0.56,0.5,0.28,0.78,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, CH Polman</text>
   <text y="508.583" x="511.912" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="511.103" x="514.837,517.087" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="522.101" x="297.262,302.266,304.516,310.519,314.515,317.512,322.012,326.512,331.012" svgx:width="0.56,0.25,0.67,0.44,0.33,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">F Barkhof</text>
   <text y="519.583" x="334.007" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="522.103" x="336.931,339.181,341.431,346.435,349.936,358.432,360.682,365.686,370.186,374.686,381.184,385.18,387.682" svgx:width="0.25,0.25,0.56,0.39,0.94,0.25,0.56,0.5,0.5,0.72,0.44,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, PJW Pouwels</text>
   <text y="519.583" x="391.183" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="522.103" x="394.108,396.358,398.608,402.109,405.61,412.108,414.358,420.856,424.852,429.352,432.349,434.851" svgx:width="0.25,0.25,0.39,0.39,0.72,0.25,0.72,0.44,0.5,0.33,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, JJG Geurts</text>
   <text y="519.583" x="438.351" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="530.581" x="297.261" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="533.103" x="300.185,305.684,312.182,314.432,320.93,325.43,327.932,331.928,335.924,339.425,342.926,345.428,347.93,351.926,354.176,361.673,365.669,370.169,372.671,376.667,381.167,383.669,385.919,391.922,395.918,400.418,402.92,406.916,410.417,412.667,414.917,420.416,424.916,429.416,431.918,436.418,438.92,443.42,447.92,451.916,454.166,458.666,463.166,467.666,469.916,475.919,480.419,484.415,486.917,490.913,495.413,498.914" svgx:width="0.61,0.72,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.61,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.25,0.5,0.5,0.5,0.25,0.67,0.5,0.44,0.28,0.44,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">VU University Medical Center, Radiology and Nuclear </text>
   <text y="544.101" x="297.26,304.757,308.753,313.253,315.755,319.751,322.253,326.753,330.749,332.999,335.249,340.748,347.246,350.747,353.249,357.245,360.746,365.246,369.746,376.244,378.494,380.744,386.747,390.743,393.245,397.745,401.741,405.242,407.744,412.244,416.744,421.244,424.745,426.995" svgx:width="0.83,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.25,0.25,0.61,0.72,0.39,0.28,0.44,0.39,0.5,0.5,0.72,0.25,0.25,0.67,0.44,0.28,0.5,0.44,0.39,0.28,0.5,0.5,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Medicine, Amsterdam, Netherlands, </text>
   <text y="541.583" x="429.243" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="544.103" x="432.168,437.667,444.165,446.415,452.913,457.413,459.915,463.911,467.907,471.408,474.909,477.411,479.913,483.909,486.159,493.656,497.652,502.152,504.654,508.65,513.15,515.652" svgx:width="0.61,0.72,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">VU University Medical </text>
   <text y="555.101" x="297.258,303.261,307.257,311.757,314.259,318.255,321.756,324.006,326.256,331.755,336.255,340.755,343.257,347.757,354.255,358.251,360.501,365.001,369.501,374.001,376.251,382.254,386.25,390.75,394.251,398.751,402.252,406.248,408.75,412.746,417.246,421.242,425.238,428.739,430.989,433.239,438.738,445.236,448.737,451.239,455.235,458.736,463.236,467.736,474.234,476.484,478.734,484.737,488.733,491.235,495.735,499.731,503.232,505.734,510.234,514.734,519.234,522.735,524.985" svgx:width="0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.61,0.5,0.5,0.28,0.5,0.72,0.44,0.25,0.5,0.5,0.5,0.25,0.67,0.44,0.5,0.39,0.5,0.39,0.44,0.28,0.44,0.5,0.44,0.44,0.39,0.25,0.25,0.61,0.72,0.39,0.28,0.44,0.39,0.5,0.5,0.72,0.25,0.25,0.67,0.44,0.28,0.5,0.44,0.39,0.28,0.5,0.5,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Center, Anatomy and Neurosciences, Amsterdam, Netherlands, </text>
   <text y="563.583" x="297.26" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="566.103" x="300.185,305.684,312.182,314.432,320.93,325.43,327.932,331.928,335.924,339.425,342.926,345.428,347.93,351.926,354.176,361.673,365.669,370.169,372.671,376.667,381.167,383.669,385.919,391.922,395.918,400.418,402.92,406.916,410.417,412.667,414.917,420.92,424.916,429.416,432.917,437.417,439.919,444.419,448.919,452.915,455.165,457.415,462.914,469.412,472.913,475.415,479.411,482.912,487.412,491.912,498.41,500.66" svgx:width="0.61,0.72,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.61,0.72,0.39,0.28,0.44,0.39,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">VU University Medical Center, Neurology, Amsterdam, </text>
   <text y="577.101" x="297.26,303.263,307.259,309.761,314.261,318.257,321.758,324.26,328.76,333.26,337.76,341.261,343.511" svgx:width="0.67,0.44,0.28,0.5,0.44,0.39,0.28,0.5,0.5,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Netherlands, </text>
   <text y="574.583" x="345.76" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="577.103" x="348.685,354.184,360.682,362.932,369.43,373.93,376.432,380.428,384.424,387.925,391.426,393.928,396.43,400.426,402.676,410.173,414.169,418.669,421.171,425.167,429.667,432.169,434.419,440.422,444.418,448.918,451.42,455.416,458.917,461.167,463.417,468.916,473.416,477.412,480.913,483.415,487.411,490.913,493.163,500.165,502.415,509.912,513.908,518.408,520.91,524.906,529.406,531.908" svgx:width="0.61,0.72,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.61,0.5,0.44,0.39,0.28,0.44,0.39,0.25,0.78,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">VU University Medical Center, Physics &amp; Medical </text>
   <text y="588.101" x="297.259,302.263,306.259,310.255,314.755,319.255,323.755,326.257,330.757,335.257,339.253,341.503,343.753,349.252,355.75,359.251,361.753,365.749,369.25,373.75,378.25,384.748,386.998,389.248,395.251,399.247,401.749,406.249,410.245,413.746,416.248,420.748,425.248,429.748" svgx:width="0.56,0.44,0.44,0.5,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.61,0.72,0.39,0.28,0.44,0.39,0.5,0.5,0.72,0.25,0.25,0.67,0.44,0.28,0.5,0.44,0.39,0.28,0.5,0.5,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Technology, Amsterdam, Netherlands</text>
   <text y="615.101" x="297.259,303.442,308.122,312.298,317.482,322.162,326.176,330.856,336.04,341.224,346.408,349.585" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="615.101" x="354.139,359.818,364.498,368.674,370.924,373.228,377.404,382.084,384.766,387.448,390.625,393.307,397.987,401.164,403.846,408.022,415.204,422.386,426.562,429.244,433.924,437.101,441.781,444.031,446.335,450.511,453.526,456.703,460.879,465.055,467.737,469.987,472.291,476.971,480.148,482.398,484.702,489.382,493.558,496.24,500.416,503.098,505.78,509.956,514.636,521.818,525.994,530.674,532.924" svgx:width="0.61,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The anti-inflammatory effect of natalizumab, </text>
   <text y="626.099" x="297.259,300.94,305.116,309.292,313.972,318.652,323.332,326.509,329.191,331.873,336.553,340.729,342.979,344.05,346.732,351.412,355.588,358.765,362.941,367.621,372.301,374.551,375.622,378.799,383.479,386.656,388.906,389.977,393.154,397.33,400.012,404.188,408.868,412.549,415.231,419.911,424.591,427.768,430.945,435.121,442.303,444.985,447.667,450.349,453.031,457.711,462.391,464.641,465.712,472.894,477.574,480.256,482.938,485.62,490.3,492.982,497.158,499.408,500.479,504.16,508.336,511.018,515.194,518.371,523.051,526.732,529.414,532.916" svgx:width="0.39,0.44,0.44,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">second-line therapy for relapsing-remitting multiple sclerosis </text>
   <text y="637.097" x="297.259,300.436,306.619,312.802,320.983,326.167,329.344,331.621,334.303,338.983,341.26,348.442,353.122,356.803,359.485,361.762,365.938,370.618,375.298,379.978,382.66,385.837,388.519,392.695,396.376,398.806,401.083,403.765,407.941,412.117,416.797,420.478,422.755,425.437,430.117,432.394,436.57,438.847,443.527,446.704,450.88,458.062,462.238,464.92,467.602,471.778,474.055,477.232,481.408,486.088,490.768,494.944,497.626,500.308,504.988,509.668,511.945,514.627,519.307,521.584,524.266,528.946,532.942" svgx:width="0.33,0.67,0.67,0.89,0.56,0.33,0.25,0.28,0.5,0.25,0.78,0.5,0.39,0.28,0.25,0.44,0.5,0.5,0.5,0.28,0.33,0.28,0.44,0.39,0.25,0.25,0.28,0.44,0.44,0.5,0.39,0.25,0.28,0.5,0.25,0.44,0.25,0.5,0.33,0.44,0.78,0.44,0.28,0.28,0.44,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(RRMS) in most countries, leads to a dramatic reduction in the </text>
   <text y="648.095" x="297.259,300.436,305.116,308.293,315.475,319.651,322.333,325.015,329.695,334.375,336.625,338.65,343.33,346.507,348.757,350.782,357.46,362.14,364.822,367.504,371.68,373.93,375.955,383.137,387.313,389.995,392.677,396.853,400.03,402.28,404.305,407.482,416.158,424.339,427.516,429.766,431.791,434.473,438.649,442.33,445.012,449.692,454.372,458.053,460.483,462.733,464.758,468.934,471.184,473.209,477.889,482.065,486.241,489.418,493.594,497.77,501.451,505.627,507.877,509.902,512.584,517.264,519.514,521.539,524.221,528.901,532.897" svgx:width="0.33,0.5,0.33,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.25,0.55,0.78,0.44,0.28,0.28,0.44,0.33,0.25,0.55,0.33,0.94,0.89,0.33,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.25,0.55,0.44,0.25,0.55,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">formation of white matter (WM) lesions, a decrease in the </text>
   <text y="659.093" x="297.259,303.937,308.617,313.297,315.979,320.155,323.332,328.012,331.189,335.365,338.047,342.727,345.598,349.774,352.456,355.633,360.313,364.993,369.673,374.353,377.224,380.401,384.577,387.259,391.435,394.306,398.482,402.163,405.034,411.712,415.888,418.57,421.252,424.123,428.299,431.98,434.851,437.533,444.715,449.395,452.572,457.252,461.932,466.108,470.788,473.659,476.836,481.012,483.694,487.87,491.551,494.422,499.102,502.279,505.15,509.326,512.008,514.69,519.37,522.052,526.228,530.404,532.906" svgx:width="0.72,0.5,0.5,0.28,0.44,0.33,0.5,0.33,0.44,0.28,0.5,0.25,0.44,0.28,0.33,0.5,0.5,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.25,0.44,0.39,0.25,0.72,0.44,0.28,0.28,0.25,0.44,0.39,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.33,0.44,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">whole-brain atrophy rate as well as improved rates of clinical </text>
   <text y="670.091" x="297.259,301.939,305.116,309.796,314.476,317.653,321.829,325.51,329.191,331.873,336.553,341.233,343.483,344.464,348.64,353.32,358.0,360.25,361.231,364.408,368.584,371.266,375.442,380.122,383.803,387.979,391.66,394.09,396.34,397.321,402.505,405.682,409.858,414.538,417.22,421.9,426.58,430.261,432.511,433.492,437.173,441.853,446.029,450.205,452.887,456.064,460.744,464.425,468.601,473.281,477.961,482.641,484.891,485.872,489.553,492.235,496.915,501.595,504.277,508.453,512.134,514.384,515.365,520.045,524.221,528.901,532.897" svgx:width="0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.55,0.56,0.33,0.44,0.5,0.28,0.5,0.5,0.39,0.25,0.55,0.39,0.5,0.44,0.44,0.28,0.33,0.5,0.39,0.44,0.5,0.5,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.5,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">progression and relapses. Previous spectroscopy studies have </text>
   <text y="681.089" x="297.259,300.94,305.62,310.3,316.978,321.658,323.908,324.889,327.571,332.251,336.427,339.109,341.359,342.34,347.02,351.196,353.878,356.56,360.736,365.416,368.098,371.779,374.029,375.01,377.692,380.869,385.045,389.221,391.903,396.079,400.759,403.009,403.99,410.668,413.35,416.032,420.712,422.962,423.943,426.625,431.305,433.987,438.163,441.34,444.517,448.693,451.87,456.55,461.23,463.48,464.461,469.141,473.317,475.999,480.175,483.352,488.032,492.712,494.962,495.943,499.12,502.297,507.481,514.159,518.839,522.016,524.266,525.247,529.927,532.924" svgx:width="0.39,0.5,0.5,0.72,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.5,0.5,0.25,0.55,0.33,0.33,0.56,0.72,0.5,0.33,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">shown that patients treated with interferon beta-1b (IFNb) or </text>
   <text y="692.087" x="297.259,301.939,304.621,308.797,311.479,314.161,317.338,321.514,328.696,332.872,336.049,338.524,342.7,346.876,351.052,353.734,357.91,360.592,364.768,367.243,370.42,377.098,383.776,386.953,389.428,394.108,398.284,402.964,407.14,409.615,412.297,416.977,421.153,424.33,428.506,432.682,436.363,440.539,445.219,447.694,450.376,455.056,457.738,461.914,464.596,467.071,473.749,476.926,481.102,485.278,489.454,492.136,496.816,499.498,503.674,507.355,512.035,516.211,519.388,522.07,526.246,528.928,532.924" svgx:width="0.5,0.28,0.44,0.28,0.28,0.33,0.44,0.78,0.44,0.33,0.25,0.44,0.44,0.44,0.28,0.44,0.28,0.44,0.25,0.33,0.72,0.72,0.33,0.25,0.5,0.44,0.5,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.72,0.33,0.44,0.44,0.44,0.28,0.5,0.28,0.44,0.39,0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">glatiramer acetate (GA) have increased total N-acetylaspartate </text>
   <text y="703.085" x="297.259,301.939,306.619,310.795,313.972,316.222,318.157,320.839,325.519,328.201,332.377,335.059,337.309,339.244,343.42,346.597,350.773,354.949,357.631,360.313,364.993,369.169,371.419,373.354,376.531,379.213,385.891,392.569,399.247,401.929,404.611,410.794,413.971,417.148,419.398,421.333,424.51,428.686,431.368,434.05,438.73,442.411,444.841,447.091,449.026,455.704,460.384,464.56,467.737,471.913,476.089,479.77,482.02,483.955,486.637,491.317,495.493,497.743,499.678,503.854,506.869,510.046,514.222,518.398,521.08,523.33,525.265,529.945,532.942" svgx:width="0.5,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.28,0.44,0.28,0.25,0.55,0.44,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.33,0.28,0.72,0.72,0.72,0.28,0.28,0.67,0.33,0.33,0.25,0.55,0.33,0.44,0.28,0.28,0.5,0.39,0.25,0.25,0.55,0.72,0.5,0.44,0.33,0.44,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">over total creatine (tNAA/tCr) ratios, whereas the effect of </text>
   <text y="714.083" x="297.259,301.939,306.115,308.797,312.973,315.655,318.337,322.513,327.193,334.375,338.551,343.231,345.481,350.539,355.219,359.899,362.149,367.207,371.887,375.064,379.24,381.922,386.602,388.852,393.91,401.092,405.268,407.95,412.126,416.806,421.486,424.168,426.85,429.532,433.708,435.958,441.016,445.192,449.872,454.552,458.728,462.904,467.584,470.266,473.443,477.619,480.301,482.983,487.663,492.343,496.024,498.274,503.332,506.509,510.685,517.867,522.043,524.725,529.405,532.906" svgx:width="0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.33,0.44,0.28,0.5,0.25,0.55,0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.28,0.44,0.25,0.55,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">natalizumab on brain metabolite concentrations remains </text>
   <text y="725.081" x="297.259,301.939,306.619,311.299,315.979,320.659,327.337,332.017" svgx:width="0.5,0.5,0.5,0.5,0.5,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">unknown.</text>
  </g>
 </g>
</svg>
